Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1050.Time spend outdoors in summer,38611,0.0231939874825743,0.02639075966836,-0.0285319014674113,0.07491987643256,0.379478459741961
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1060.Time spent outdoors in winter,33671,0.0616352096865984,0.0299130549212579,0.00300562204093287,0.120264797332264,0.039360476930038
LYZL2,Lysozyme-like protein 2,Physical activities,X1070.Time spent watching television (TV),40635,0.00649225492709955,0.0265714544505353,-0.0455877957959497,0.0585723056501488,0.806974985003373
LYZL2,Lysozyme-like protein 2,Physical activities,X1080.Time spent using computer,33681,-0.0144217697682885,0.0273975704087839,-0.0681210077695049,0.0392774682329279,0.598621676203612
LYZL2,Lysozyme-like protein 2,Physical activities,X1090.Time spent driving,29260,0.006154383325303,0.0298710968252665,-0.0523929664522194,0.0647017331028254,0.836767832941898
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1160.Sleep duration,42796,0.0158606992437072,0.0243697905661076,-0.0319040902658637,0.0636254887532781,0.515156854580894
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,13962,-0.00542491617660585,0.0101753944195799,-0.0253686892389825,0.0145188568857708,0.593944730870322
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,13962,0.00861195783697945,0.00992105317408536,-0.0108333063842279,0.0280572220581868,0.38538257835398
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,13962,0.00567107297814478,0.0112039932085104,-0.0162887537105357,0.0276308996668252,0.612748587595048
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,13962,0.0242764479051056,0.0114416394613582,0.00185083456084358,0.0467020612493677,0.0338752209782846
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,13962,0.0142732916596859,0.0116073893970119,-0.0084771915584574,0.0370237748778292,0.218840377140655
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,13962,0.00295993344280959,0.0249433959449633,-0.0459291226093185,0.0518489894949376,0.905541669765411
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,13962,-0.00709108710674809,0.0253770620356967,-0.0568301286967137,0.0426479544832175,0.779919760247656
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,13962,0.000928097842398115,0.0178104026779109,-0.0339802914063073,0.0358364870911035,0.95844189143963
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,13962,0.00548093049105789,0.013168015622438,-0.0203283801289205,0.0312902411110363,0.677247705186256
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,13962,0.000133895110199477,0.00891388600049274,-0.0173373214507663,0.0176051116711652,0.988015674774137
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,13962,0.0048500033774065,0.0128774219352735,-0.0203897436157296,0.0300897503705426,0.7064554760767
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,13962,-0.00421796327726457,0.00724060338331926,-0.0184095459085703,0.00997361935404117,0.560210360341911
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,13962,-0.00178886995430084,0.00931339811436211,-0.0200431302584506,0.0164653903498489,0.847686336667833
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,13962,0.0100272355027443,0.013760155160384,-0.0169426686116084,0.0369971396170969,0.466188070586064
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,13962,0.00834110936715316,0.0129079952214978,-0.0169585612669826,0.0336407800012889,0.518162334529413
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,13962,0.00826486443813112,0.0171296397477039,-0.0253092294673685,0.0418389583436307,0.629466112502573
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,13962,0.00123989469545356,0.0165943368109925,-0.0312850054540917,0.0337647948449989,0.94044020342756
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,13962,0.00136722461054162,0.0100814986139689,-0.0183925126728374,0.0211269618939207,0.892125864746894
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,13962,0.0134846808301087,0.00954657129767038,-0.00522659891332525,0.0321959605735426,0.157820513760233
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,13962,0.00725771493189404,0.0119417506852859,-0.0161481164112664,0.0306635462750545,0.543356749585437
LYZL2,Lysozyme-like protein 2,Health and medical history,X120040.Fatigue severity over the past week,13977,0.0397314291306587,0.0441150821594772,-0.0467341319019166,0.126196990163234,0.367799857834106
LYZL2,Lysozyme-like protein 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,13977,0.00390219599800489,0.0440513913438379,-0.0824385310359173,0.0902429230319271,0.929414741148613
LYZL2,Lysozyme-like protein 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,13975,0.0807519737605345,0.0478120086774014,-0.0129595632471722,0.174463510768241,0.0912518203690332
LYZL2,Lysozyme-like protein 2,Health and medical history,X120098.Mobility problems today,13983,0.0177271899598228,0.0522383597316018,-0.0846599951141168,0.120114375033762,0.734349703614045
LYZL2,Lysozyme-like protein 2,Health and medical history,X120099.Self-care problems today,13983,0.0734356224185696,0.0789632138373876,-0.08133227670271,0.228203521539849,0.352388250033345
LYZL2,Lysozyme-like protein 2,Health and medical history,X120100.Problems doing usual activities,13983,0.0200990308470064,0.0498776759370828,-0.0776612139896759,0.117859275683689,0.686979061673117
LYZL2,Lysozyme-like protein 2,Health and medical history,X120101.Pain or discomfort today,13983,-0.00995458940910066,0.0443239353224127,-0.0968295026410296,0.0769203238228283,0.822303693511121
LYZL2,Lysozyme-like protein 2,Health and medical history,X120102.Anxiety or depression today,13983,-0.0289350119341094,0.0541570774198032,-0.135082883676924,0.0772128598087049,0.59315673263211
LYZL2,Lysozyme-like protein 2,Health and medical history,X120103.Scale to indicate how health is today,13936,-3.86194545811736e-05,0.00312527658569767,-0.0061641615625486,0.00608692265338626,0.990140863326488
LYZL2,Lysozyme-like protein 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,13945,-0.0104658773371591,0.0546754944443686,-0.117629846448122,0.0966980917738033,0.848200858137951
LYZL2,Lysozyme-like protein 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",13921,-0.0987371380382837,0.057012576920289,-0.21048178880205,0.0130075127254827,0.0833227420656202
LYZL2,Lysozyme-like protein 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",13955,0.0114189629724177,0.0440558249801028,-0.0749304539885838,0.0977683799334191,0.795490132553023
LYZL2,Lysozyme-like protein 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,13958,0.0590714174481903,0.0451696056141484,-0.0294610095555406,0.147603844451921,0.190973178639593
LYZL2,Lysozyme-like protein 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,13962,-0.0187564600217409,0.0590469528683755,-0.134488487643757,0.0969755676002751,0.750752687082855
LYZL2,Lysozyme-like protein 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,13925,-0.0389431455478104,0.0592070146923401,-0.154988894344797,0.0771026032491762,0.510712585855606
LYZL2,Lysozyme-like protein 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,13963,0.0800229053982119,0.0582364429238441,-0.0341205227325226,0.194166333528946,0.169431605763069
LYZL2,Lysozyme-like protein 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,13948,-0.0283270397739745,0.087664914029189,-0.200150271271185,0.143496191723236,0.746602710973981
LYZL2,Lysozyme-like protein 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,13883,-0.21368761051051,0.123819169377026,-0.456373182489481,0.0289979614684608,0.0844049670043931
LYZL2,Lysozyme-like protein 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",9695,0.00141011598388889,0.0593572508784181,-0.114930095737811,0.117750327705588,0.981047389036293
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,38633,-0.0740145903722295,0.0606555681575707,-0.192899503961068,0.0448703232166091,0.222379859921963
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,36052,-0.01830710673716,0.0363620845100846,-0.0895767923769258,0.0529625789026057,0.614639108785615
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1289.Cooked vegetable intake,41548,-0.0371973072766513,0.0255072249261769,-0.0871914681319579,0.0127968535786554,0.14476412309328
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,40440,-0.0287618660517694,0.0268602003111898,-0.0814078586617013,0.0238841265581625,0.284266370094419
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1309.Fresh fruit intake,41476,-0.0175348714425232,0.0264955844705721,-0.0694662170048446,0.0343964741197981,0.508100818883998
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1319.Dried fruit intake,39192,-0.0337347519494724,0.0274694907131233,-0.087574953747194,0.0201054498482492,0.219424045504938
LYZL2,Lysozyme-like protein 2,Health and medical history,X134.Number of self-reported cancers,43171,0.216288665526583,0.0443920586185408,0.129280230634243,0.303297100418923,1.1073189419297e-06
LYZL2,Lysozyme-like protein 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,43172,0.0112079856550054,0.0252166134779371,-0.0382165767617514,0.0606325480717622,0.65670626200979
LYZL2,Lysozyme-like protein 2,Health and medical history,"X136.Number of operations, self-reported",43172,0.0696036055078658,0.0249220059935149,0.0207564737605767,0.118450737255155,0.00522677352075181
LYZL2,Lysozyme-like protein 2,Health and medical history,X137.Number of treatments or medications taken,43172,0.0225385346151992,0.0247480388074528,-0.0259676214474083,0.0710446906778067,0.362447994720704
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1438.Bread intake,41910,0.00432226697785476,0.00189919587305877,0.000599843066659574,0.00804469088904995,0.0228605795315964
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1458.Cereal intake,40956,0.0694212990114653,0.025372506727938,0.0196911858247067,0.119151412198224,0.00622020242823903
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1488.Tea intake,41634,0.00181774342128917,0.00181662213966381,-0.00174283597245189,0.00537832281503023,0.317017712113432
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1498.Coffee intake,39785,-0.0375244818695963,0.0253610037756979,-0.0872320492699643,0.0121830855307716,0.138984360257351
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1528.Water intake,39964,-0.0512591671819743,0.0257605196084252,-0.101749785614488,-0.000768548749460862,0.0466159897713809
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1568.Average weekly red wine intake,29344,-0.0268936400689588,0.0298587645145649,-0.085416818517506,0.0316295383795884,0.367757900569667
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,29342,-0.0524022973791501,0.0304647935059725,-0.112113292650856,0.00730869789255606,0.0854259724013807
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,29424,0.00426012632875205,0.0336430749833857,-0.0616803006386839,0.070200553296188,0.899236381776204
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1598.Average weekly spirits intake,29305,0.0293275965990389,0.0326140834239513,-0.0345960069119057,0.0932512001099835,0.368536995293979
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1608.Average weekly fortified wine intake,29400,0.0634344792906693,0.0531142487287752,-0.0406694482177301,0.167538406799069,0.23236930588137
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1737.Childhood sunburn occasions,32398,-0.00119020617528774,0.0299648009442584,-0.0599212160260341,0.0575408036754586,0.968316487499
LYZL2,Lysozyme-like protein 2,Health and medical history,X1807.Father's age at death,31881,0.000427924514763866,0.00208545047329338,-0.00365955841289116,0.00451540744241889,0.837420897216701
LYZL2,Lysozyme-like protein 2,Health and medical history,X1845.Mother's age,16422,-0.00448120333677198,0.004824095110003,-0.0139364297523779,0.0049740230788339,0.35294368508241
LYZL2,Lysozyme-like protein 2,Health and medical history,X1873.Number of full brothers,42406,-0.0168988986521269,0.0243361773414132,-0.0645978062412967,0.030800008937043,0.487438880445175
LYZL2,Lysozyme-like protein 2,Health and medical history,X1883.Number of full sisters,42409,0.0235870120481978,0.0243588941046704,-0.0241564203969562,0.0713304444933518,0.332894044634549
LYZL2,Lysozyme-like protein 2,Physical measures,X20015.Sitting height,42834,-0.00847299219761239,0.00238923718491001,-0.013155897080036,-0.00379008731518877,0.000391073009563831
LYZL2,Lysozyme-like protein 2,Cognitive function,X20016.Fluid intelligence score,14019,0.0241347896126326,0.0396248787973624,-0.0535299728301976,0.101799552055463,0.542480156942877
LYZL2,Lysozyme-like protein 2,Cognitive function,X20018.Prospective memory result,14604,-0.0661214377782514,0.0537904108198282,-0.171550642985115,0.0393077674286119,0.219000872343458
LYZL2,Lysozyme-like protein 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),13840,-0.00263445178715124,0.00330825215047132,-0.00911862600207502,0.00384972242777254,0.425855444614402
LYZL2,Lysozyme-like protein 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),13830,-0.006312822570768,0.003295212734231,-0.0127714395298608,0.000145794388324767,0.0554168158876915
LYZL2,Lysozyme-like protein 2,Cognitive function,X20023.Mean time to correctly identify matches,42652,0.00378603727799076,0.00191933881903455,2.4133192683037e-05,0.00754794136329849,0.04855060222119
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,37586,-0.00357421696073499,0.00410923506435268,-0.0116283176868662,0.00447988376539626,0.384414695919676
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,36857,-0.00502156629865323,0.00903344035782039,-0.0227271093999812,0.0126839768026747,0.57829191741536
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,36794,-0.0111300996301284,0.0122105048974508,-0.0350626892291319,0.012802489968875,0.362028280339538
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,36834,0.00593479137003852,0.0101579547606039,-0.0139747999607451,0.0258443827008221,0.559055288500653
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,36860,0.00423625779140337,0.00730024265805435,-0.0100722178183831,0.0185447334011899,0.561722620386261
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#2.Illnesses of father_Stroke,37133,0.00982075625103002,0.00530579516705856,-0.000578602276404765,0.0202201147784648,0.0641848292829199
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,37043,0.00526297589733288,0.00669747234985309,-0.00786406990837918,0.0183900217030449,0.431980760230385
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,36865,-0.00789445390140246,0.00833688686092532,-0.0242347521488161,0.00844584434601118,0.343680314931628
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,37117,0.00170120026190095,0.00612291575944515,-0.0102997146266116,0.0137021151504134,0.781135560172362
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,37234,-0.00119476763406628,0.00461953049553782,-0.0102490474053204,0.00785951213718785,0.7959190802151
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,36999,0.0124143058476368,0.0063962527994043,-0.000122349639195588,0.0249509613344693,0.0522814328354426
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,39367,0.00196325850078714,0.00468913119695875,-0.00722743864525201,0.0111539556468263,0.675450264733442
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,39132,0.000518101593488377,0.00675319428547533,-0.0127181592060433,0.01375436239302,0.938847095106886
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,39005,-0.0086970021786508,0.014818679995373,-0.0377416149695819,0.0203476106122803,0.557277944093205
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,39063,0.005694369460359,0.00754325627057907,-0.00909041282997598,0.020479151750694,0.450316298747001
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,39267,-0.00843085503685533,0.00533894437225117,-0.0188951860064676,0.00203347593275697,0.114315682204287
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,39089,-0.00818794222889223,0.00947202223424266,-0.0267531058080078,0.0103772213502234,0.387354587289872
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,39054,0.00336022747463037,0.00846167241835483,-0.0132246504653451,0.0199451054146058,0.691287406622513
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,39086,-0.000377913151868452,0.00690560835370557,-0.0139129055251314,0.0131570792213945,0.956357401017182
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,39138,0.0151569896232982,0.00790506921275018,-0.000336946033692151,0.0306509252802885,0.0551974603961957
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,39449,-0.0041055272106311,0.00405225047860756,-0.0120479381487019,0.00383688372743971,0.310995956006767
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,39198,-0.00608169157816035,0.00626498353545136,-0.018361059307645,0.00619767615132431,0.331682053335405
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,33834,-0.00672073120165374,0.00659986033994045,-0.019656457467937,0.00621499506462955,0.308535968282923
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,33583,0.011885662554021,0.0266424127017504,-0.0403334663414097,0.0641047914494517,0.655514815818073
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,33576,0.0034629639146946,0.0264785665605764,-0.0484350265440351,0.0553609543734243,0.895947231205882
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,33677,-0.00170507628557006,0.00784756599489953,-0.0170863056355731,0.013676153064433,0.827995714692543
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,33602,0.0104586662647908,0.0155549459178048,-0.0200290277341065,0.0409463602636881,0.501353322117735
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,33646,0.0109136062457785,0.0110984501458778,-0.010839356040142,0.0326665685316991,0.325444708518422
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,33601,0.0157000119325106,0.0131728449350963,-0.0101187641402781,0.0415187880052992,0.233329776808694
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,33606,-0.00095698012154498,0.0129160462844542,-0.0262724308390752,0.0243584705959853,0.940937349696094
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,33626,0.00215755079290056,0.00966745743005412,-0.0167906657700055,0.0211057673558066,0.823399378076784
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,33648,-0.00321955244836091,0.0120280117482977,-0.0267944554750243,0.0203553505783025,0.788954054455267
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,33941,-0.000365829389485506,0.00493574688145944,-0.010039893277146,0.009308234498175,0.940916655287648
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,33761,-0.00664840156450832,0.00697801058023623,-0.0203253023017713,0.00702849917275469,0.340716170413559
LYZL2,Lysozyme-like protein 2,Mental health,X20127.Neuroticism score,34276,-0.000345019462403002,0.0255704579083984,-0.0504631169628638,0.0497730780380578,0.989234633930352
LYZL2,Lysozyme-like protein 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,14019,0.0182111676578655,0.0401639184629336,-0.0605101125294844,0.0969324478452154,0.650252583968297
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X20161.Pack years of smoking,13263,-0.00597374297396389,0.00348110579204359,-0.0127967103263693,0.000849224378441545,0.086176721896311
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,13263,-0.00670096472078006,0.00343339734981798,-0.0134304235264233,2.84940848631699e-05,0.0509947649065998
LYZL2,Lysozyme-like protein 2,Cognitive function,X20191.Fluid intelligence score,10420,-0.0455412125063876,0.0467173745718691,-0.137107266667251,0.0460248416544758,0.329670313932534
LYZL2,Lysozyme-like protein 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,10421,-0.00867322271093123,0.0483968219582564,-0.103530993749114,0.0861845483272514,0.857775846451015
LYZL2,Lysozyme-like protein 2,Cognitive function,X20240.Maximum digits remembered correctly,9346,-0.0497817387942855,0.0500817425531096,-0.14794195419838,0.0483784766098094,0.320243931072093
LYZL2,Lysozyme-like protein 2,Physical measures,X20255.Spirometry QC measure,31994,0.00165063647976373,0.0322658290949375,-0.0615903885463138,0.0648916615058412,0.95920040303479
LYZL2,Lysozyme-like protein 2,Eye measures,X20261.avMSE,9603,2.11615719469871e-05,0.00386229806428436,-0.00754894263405035,0.00759126577794433,0.995628517899157
LYZL2,Lysozyme-like protein 2,Eye measures,X20262.Myopia diagnosis,9603,-0.00579551532197564,0.0608992857456922,-0.125158115383532,0.113567084739581,0.924185304659069
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X20280.Glucose-lactate,23961,0.00768564323004755,0.00244567387003631,0.00289212244477639,0.0124791640153187,0.0016768945502832
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,24007,0.00927044509516179,0.0024520852172729,0.00446435806930692,0.0140765321210167,0.000156806221505072
LYZL2,Lysozyme-like protein 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,13471,0.00841833772549234,0.0129012081597217,-0.0168680302675622,0.0337047057185469,0.514074852748124
LYZL2,Lysozyme-like protein 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,13469,0.00574898623808368,0.0253922056450404,-0.0440197368261955,0.0555177093023628,0.820887921024361
LYZL2,Lysozyme-like protein 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),13469,-0.0164344863613052,0.0315520596485309,-0.0782765232724258,0.0454075505498154,0.602466678476737
LYZL2,Lysozyme-like protein 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),13469,0.00301182909433676,0.0122558927163285,-0.0210097206296671,0.0270333788183406,0.805883084083979
LYZL2,Lysozyme-like protein 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),13469,-0.017302446536085,0.0210560016661747,-0.0585722098017875,0.0239673167296175,0.411242484163779
LYZL2,Lysozyme-like protein 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,13477,-0.0306037236030755,0.0269759832356057,-0.0834766507448627,0.0222692035387117,0.256613299492119
LYZL2,Lysozyme-like protein 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,13477,-0.0051211797706666,0.0179318058932554,-0.0402675193214471,0.0300251597801139,0.775195048033149
LYZL2,Lysozyme-like protein 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,13477,-0.0251744643752844,0.0198590353339082,-0.0640981736297444,0.0137492448791756,0.204942045107459
LYZL2,Lysozyme-like protein 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,13477,0.0517990961065146,0.0307520363440853,-0.00847489512789256,0.112073087340922,0.0921252712379711
LYZL2,Lysozyme-like protein 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,13477,0.0315012702262182,0.0350023548804726,-0.0371033453395082,0.100105885791945,0.368149258611726
LYZL2,Lysozyme-like protein 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,13477,-0.00404901311675755,0.0208610706903562,-0.0449367116698557,0.0368386854363406,0.846105040491506
LYZL2,Lysozyme-like protein 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,13477,0.0391233165103528,0.0347074579957018,-0.0289033011612228,0.107149934181928,0.259664990600847
LYZL2,Lysozyme-like protein 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,13477,0.0321579649026026,0.0256454213757509,-0.0181070609938692,0.0824229907990744,0.20988352861911
LYZL2,Lysozyme-like protein 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),13479,-0.0184816908712617,0.0359591603950932,-0.0889616452456444,0.0519982635031209,0.60728604247213
LYZL2,Lysozyme-like protein 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),13479,0.0113527474882493,0.016488452476142,-0.020964619364989,0.0436701143414875,0.49113272997401
LYZL2,Lysozyme-like protein 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),13479,0.00313364943796558,0.0246057395050597,-0.0450935999919513,0.0513608988678825,0.89866179960454
LYZL2,Lysozyme-like protein 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,13480,0.00790014849985875,0.0417987504701651,-0.0740254024216649,0.0898256994213824,0.850092202613345
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20600.Liking for adding salt to foods,15242,-0.0405013960207489,0.0393004525331421,-0.117530282985707,0.0365274909442097,0.302764514299446
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20601.Liking for aniseed,15242,-0.0198074439003054,0.0392772279676723,-0.0967908107169431,0.0571759229163324,0.614058990116642
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20602.Liking for apple juice,15242,0.0337013037173238,0.0391082636774243,-0.0429508930904278,0.110353500525075,0.388842094898371
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20603.Liking for apples,15242,0.056920899150287,0.0399502774858497,-0.0213816447219784,0.135223443022552,0.154237382216509
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20604.Liking for asparagus,15242,-0.0308697401354395,0.0397909391231969,-0.108859980816905,0.0471205005460264,0.437880184366973
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20605.Liking for aubergine,15242,-0.0552341389853482,0.0395901825817948,-0.132830896845666,0.0223626188749696,0.162991763211806
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20606.Liking for avocados,15242,0.0588764660469404,0.0396161866384498,-0.0187712597644212,0.136524191858302,0.137254354656016
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20607.Liking for bacon,15242,0.00794522319795045,0.0398366085768981,-0.0701345296127698,0.0860249760086707,0.841917115029888
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20608.Liking for baked or steamed fish,15242,0.0873215948872182,0.0397296911332005,0.00945140026614517,0.165191789508291,0.0279717653288939
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20609.Liking for bananas,15242,0.103224661243513,0.0406669383506005,0.0235174620763362,0.18293186041069,0.0111493046440386
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,15242,0.0037476417959678,0.0391216834432912,-0.072930857752883,0.0804261413448186,0.923685053163975
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20611.Liking for beef steak,15242,0.046614919870053,0.0392821323486813,-0.0303780595333623,0.123607899273468,0.235376417901397
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20612.Liking for beetroot,15242,0.0857297292900959,0.0397940765581874,0.00773333923604859,0.163726119344143,0.0312296393510076
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20613.Liking for bell pepper,15242,0.000711674784422,0.0391829969464503,-0.0760869992306206,0.0775103487994646,0.985509179515869
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20614.Liking for bicycling,15242,0.0307331963989375,0.0388699129967553,-0.0454518330747028,0.106918225872578,0.429150074223058
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20615.Liking for biscuits,15242,0.0318488391279378,0.0389025857488712,-0.0444002289398497,0.108097907195725,0.412980798741908
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20616.Liking for bitter foods,15242,-0.00773078208298295,0.0388906542646877,-0.0839564644417709,0.068494900275805,0.842435529013769
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20617.Liking for bitter or ale,15242,0.0291580255622585,0.039851030352047,-0.0489499939277537,0.107266045052271,0.46437787354971
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20618.Liking for black olives,15242,0.0358740636787901,0.0393244514680184,-0.041201861198526,0.112949988556106,0.361647124211566
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20619.Liking for black pepper,15242,-0.0246770141690586,0.0396686365609878,-0.102427541828595,0.0530735134904775,0.533899434035648
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20620.Liking for blue cheese,15242,-0.0242501660674753,0.0394574584836262,-0.101586784695383,0.053086452560432,0.538834596510649
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20621.Liking for bolognese sauce,15242,0.0381437606440558,0.0393057355646211,-0.0388954810626015,0.115183002350713,0.331843875270015
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20622.Liking for broad beans,15242,0.106608699928993,0.0394697508818388,0.0292479882005889,0.183969411657397,0.00692031036129689
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20623.Liking for broccoli,15242,0.0438407166077748,0.0404158381538027,-0.0353743261736785,0.123055759389228,0.278053567116803
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20624.Liking for brown rice,15242,0.0447861796957369,0.0393706023992486,-0.0323802010067903,0.121952560398264,0.255324741998433
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20625.Liking for brussel sprouts,15242,0.0484736890887618,0.0395239158258292,-0.0289931859298635,0.125940564107387,0.220052327307526
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20626.Liking for burgers (meat),15242,0.0426466175655318,0.0387919688399357,-0.033385641360742,0.118678876491806,0.271625328415461
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20627.Liking for burn of spicy foods,15242,-0.0730546518919879,0.0391608943889619,-0.149810004894353,0.00370070111037733,0.0621305660342472
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20628.Liking for butter on bread,15242,0.0753299080872867,0.0395899650364295,-0.00226642338411515,0.152926239558689,0.0570916912046856
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20629.Liking for butternut squash,15242,0.0136614466354,0.039418414630622,-0.0635986460406192,0.0909215393114191,0.728915238996521
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20630.Liking for cabbage,15242,0.0285353614388064,0.0396076832911717,-0.04909569781189,0.106166420689503,0.471258945958821
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20631.Liking for cake,15242,-0.00363651667934465,0.0390950882966544,-0.0802628897407873,0.0729898563820979,0.925891100244398
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20632.Liking for cake icing,15242,-0.00357478862748093,0.0386599257970664,-0.0793482431897311,0.0721986659347692,0.926327789048952
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20633.Liking for capers,15242,-0.00775475313863074,0.0387002960251899,-0.0836073333480029,0.0680978270707415,0.841186323529559
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20634.Liking for cauliflower,15242,0.0864082268319464,0.0402458872875316,0.00752628774838456,0.165290165915508,0.0318084259979962
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20635.Liking for cereal or granola bar,15242,0.0236717546858658,0.0390268015915968,-0.0528207764336638,0.100164285805396,0.544157818660634
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20636.Liking for cheesecake,15242,0.063885867739379,0.0390928831087934,-0.0127361831538561,0.140507918632614,0.102236052237114
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20637.Liking for cherries,15242,0.063684895117668,0.0414802126743262,-0.0176163217240114,0.144986111959347,0.124729020469369
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20638.Liking for chicken,15242,0.0252941238872277,0.0409716386443815,-0.0550102878557601,0.105598535630216,0.537008578989008
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20639.Liking for chilli pepper,15242,-0.0606285118055305,0.0394782994145773,-0.138005978658102,0.016748955047041,0.124622275533002
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20640.Liking for chips or french fries,15242,0.0634905040342807,0.0394008695159348,-0.0137352002169516,0.140716208285513,0.107113619666264
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20641.Liking for cigarette smoking,15242,0.0605164051900633,0.0636433589264087,-0.0642245783056976,0.185257388685824,0.341686713023585
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20642.Liking for cod,15242,0.113865857201545,0.040462354784861,0.0345596418232169,0.193172072579872,0.00489739653074551
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20643.Liking for coffee with sugar,15242,-0.0203390391481321,0.0426195160521,-0.103873290610248,0.0631952123139839,0.633209755869215
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20644.Liking for coffee without sugar,15242,0.00391758796161998,0.0396039481629321,-0.0737061504377269,0.0815413263609669,0.921203785357682
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20645.Liking for coriander,15242,-0.0688962672253658,0.038991034890517,-0.145318695610779,0.00752616116004756,0.0772520962456741
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20646.Liking for corn flakes,15242,0.0988843618652111,0.0390434518251557,0.0223591962879059,0.175409527442516,0.0113295574394662
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20647.Liking for cream,15242,0.0372867676780224,0.0391805848328231,-0.0395071785943109,0.114080713950356,0.341282323638885
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20648.Liking for croissant,15242,0.0214016306405407,0.0393429673343713,-0.055710585334827,0.0985138466159084,0.586465945856169
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20649.Liking for cucumber,15242,0.0345545903314389,0.0392063650267437,-0.0422898851209787,0.111399065783856,0.378141494698501
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20650.Liking for curry,15242,-0.0187253021199563,0.0399942530737851,-0.097114038144575,0.0596634339046624,0.639648405353679
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20651.Liking for dairy products,15242,0.0603396874367375,0.039825157214193,-0.0177176207030808,0.138396995576556,0.129764087148224
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20652.Liking for dark chocolate,15242,-0.0284181034572741,0.0393979338141289,-0.105638053732967,0.0488018468184186,0.470730201285468
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,15242,0.0363070801480603,0.0403674798649335,-0.0428131803872093,0.11542734068333,0.368446367425574
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20654.Liking for dried fruit,15242,0.0720508263079559,0.039249209466184,-0.00487762424576479,0.148979276861677,0.0664175690107308
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20655.Liking for eggs,15242,0.0555365233806528,0.0402743353548725,-0.0234011739148973,0.134474220676203,0.167928685312077
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20656.Liking for exercising alone,15242,0.0348699852820583,0.0389436934510928,-0.0414596538820837,0.1111996244462,0.370590176423311
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20657.Liking for exercising with others,15242,-0.00471578749173965,0.0385806334960354,-0.0803338291439691,0.0709022541604898,0.902716908304787
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,15242,0.000514897423457091,0.0394689653585493,-0.0768442746792995,0.0778740695262137,0.989591561396189
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20659.Liking for fatty foods,15242,-0.0111276222460764,0.0391388336600193,-0.0878397362197142,0.0655844917275614,0.776175507881679
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20660.Liking for fresh tomatoes,15242,0.0198564312375801,0.0423850747586981,-0.0632183152894682,0.102931177764628,0.639450248666897
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20661.Liking for fried chicken,15242,0.0532182833995086,0.0389221188380227,-0.0230690695230158,0.129505636322033,0.171550918661267
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20662.Liking for fried or battered fish,15242,0.0576225702110081,0.0392409484525579,-0.0192896887560053,0.134534829178022,0.14200823375516
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20663.Liking for fruit,15242,0.063314733456642,0.0440902954374073,-0.0231022456006763,0.14973171251396,0.151015994307257
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20664.Liking for garlic,15242,0.0386040392166923,0.0394738854774795,-0.0387647763191675,0.115972854752552,0.328107670904634
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20665.Liking for gherkins,15242,-0.0250257946353217,0.0391947739036243,-0.101847551486425,0.0517959622157818,0.523158999232873
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20666.Liking for globe artichoke,15242,0.0226057991270651,0.038972134691148,-0.0537795848675849,0.0989911831217152,0.561889272896603
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20667.Liking for goat's cheese,15242,0.0411870186375903,0.0389116087467029,-0.0350797345059474,0.117453771781128,0.289855114577696
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20668.Liking for going to a cafe,15242,-0.0363948355583092,0.0392266580220761,-0.113279085281578,0.04048941416496,0.353521511271467
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20669.Liking for going to the gym,15242,-0.00910350224039912,0.0385219641326028,-0.0846065519403005,0.0663995474595023,0.813187716564829
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20670.Liking for going to the pub,15242,-0.0279400345467367,0.039139132837695,-0.104652734908619,0.0487726658151455,0.475321964765666
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20671.Liking for grapefruit,15242,0.0058579204821496,0.0389465315797314,-0.0704772814141239,0.0821931223784231,0.880443699101366
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20672.Liking for green olives,15242,0.00579353347459049,0.0391226331618521,-0.0708868275226397,0.0824738944718207,0.882276472141852
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20673.Liking for haddock,15242,0.00369098969601014,0.0402196265404556,-0.0751394783232828,0.0825214577153031,0.926881304930985
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20674.Liking for ham,15242,0.0640620572409199,0.0390992913573122,-0.012572553819412,0.140696668301252,0.101349469522859
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20675.Liking for hard cheese,15242,0.0550007401453452,0.0403123202657384,-0.024011407575502,0.134012887866192,0.172472725468356
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20676.Liking for herring,15242,-0.0382582424630426,0.0388608106681218,-0.114425431372561,0.0379089464464762,0.324888235545633
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20677.Liking for honey,15242,-0.0102496564437673,0.0389842342139345,-0.0866587555030789,0.0661594426155443,0.792617350117784
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,15242,-0.0815917929497671,0.0389441602405332,-0.157922347021212,-0.00526123887832206,0.0361788571051215
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20679.Liking for ice cream,15242,-0.018581167637539,0.0395109996552767,-0.0960227269618814,0.0588603916868033,0.638162903777805
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20680.Liking for jam,15242,0.0275186487321304,0.0390313559063287,-0.0489828088442738,0.104020106308535,0.480796427379721
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20681.Liking for kiwi fruit,15242,0.105063521782504,0.0388206084494917,0.0289751292214999,0.181151914343508,0.00680959191907543
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20682.Liking for lager,15242,-0.0147908271869375,0.0390897527813124,-0.0914067426383099,0.0618250882644349,0.705152716944729
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20683.Liking for lamb,15242,0.0326169311503466,0.0397484393441154,-0.0452900099641196,0.110523872264813,0.41189614829933
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20684.Liking for lemons,15242,0.00233988156517322,0.0396223196994912,-0.0753198650458296,0.079999628176176,0.952909368176436
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20685.Liking for lentils or beans,15242,0.0123811591009314,0.0398188664968264,-0.0656638192328484,0.0904261374347112,0.755852770182022
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20686.Liking for liver,15242,0.0769287391151902,0.0394066082283124,-0.000308213012302119,0.154165691242682,0.0509353094141982
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20687.Liking for mackerel,15242,0.0274878626488003,0.0392098759334568,-0.049363494180775,0.104339219478376,0.483286045903752
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20688.Liking for marzipan,15242,0.0933720351040787,0.0391415564133464,0.0166545845339198,0.170089485674238,0.0170682562519357
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20689.Liking for mayonnaise,15242,0.101416370114167,0.0393711647195859,0.024248887263779,0.178583852964556,0.0100071616627609
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20690.Liking for melon,15242,0.0395663203178271,0.0404550642012319,-0.0397256055165874,0.118858246152242,0.328074374041664
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20691.Liking for milk chocolate,15242,0.0414633699310831,0.0391864862920234,-0.0353421432012828,0.118268883063449,0.290024917489514
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20692.Liking for mushrooms,15242,0.0769910952039041,0.0405247550487189,-0.00243742469158501,0.156419615099393,0.057471239676207
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20694.Liking for orange juice,15242,0.0779126064046691,0.0389526296819383,0.00156545222807006,0.154259760581268,0.0454976369769279
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20695.Liking for oranges,15242,-0.0208536100226232,0.0401208157801104,-0.0994904089516396,0.0577831889063931,0.603231214399877
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20696.Liking for pasta,15242,0.0727317539519003,0.0396272533448584,-0.00493766260402215,0.150401170507823,0.0664663448782236
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20697.Liking for pears,15242,0.0871101726334816,0.0400066804919891,0.008697078869183,0.16552326639778,0.0294667405982301
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20698.Liking for pizza,15242,-0.00704084045095227,0.0393141356480181,-0.0840965463210678,0.0700148654191633,0.857867981985509
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20699.Liking for plain yogurt,15242,0.0103443016907274,0.0389269788113473,-0.0659525767795132,0.086641180160968,0.790446094823164
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20700.Liking for plums,15242,0.0290360618695141,0.0401108447430627,-0.0495811938268889,0.107653317565917,0.469140991096797
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20701.Liking for pollock,15242,-0.0015625637425062,0.0388581624243499,-0.077724562094232,0.0745994346092196,0.967924652272721
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20702.Liking for pork chop,15242,0.0564951214166104,0.0388463365242966,-0.019643698171011,0.132633941004232,0.14587739363359
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20703.Liking for porridge,15242,0.0968913635035262,0.0398336038658046,0.0188174999265492,0.174965227080503,0.015010470502536
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20704.Liking for potato crisps,15242,-0.0223725982530946,0.0392787351235044,-0.0993589190951631,0.0546137225889739,0.56896726746233
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20705.Liking for potatoes,15242,0.0659147199075516,0.0396589869218614,-0.0118168944592967,0.1436463342744,0.0965258670376951
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20706.Liking for prawns,15242,0.0546857279791131,0.0401440176776009,-0.0239965466689847,0.133368002627211,0.173142777167399
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20707.Liking for raw carrots,15242,0.0412472297180836,0.0394465360482039,-0.0360679809363959,0.118562440372563,0.295739739189586
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20708.Liking for red meat,15242,0.0274922717054348,0.0392966929990796,-0.0495292465727613,0.104513789983631,0.484182982294749
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20709.Liking for red wine,15242,-0.0203068430782316,0.0395501389625445,-0.0978251154448188,0.0572114292883556,0.607647139289032
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,15242,-0.0437915930574326,0.0405600178349386,-0.123289228013912,0.0357060418990471,0.28030452573317
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20711.Liking for roast chicken,15242,0.0395338654548478,0.0409805602730478,-0.040788032680326,0.119855763590022,0.334711414334539
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20712.Liking for salad dressing,15242,0.0865482957156953,0.0391496273092822,0.00981502618950214,0.163281565241888,0.0270710542995583
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20713.Liking for salad leaves,15242,0.0348467626639834,0.0401094251113779,-0.0437677105543173,0.113461235882284,0.384974405236703
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20714.Liking for salami,15242,-0.0120763178108609,0.0391282957472167,-0.0887677774754055,0.0646151418536837,0.757604268604488
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20715.Liking for salmon,15242,0.0173878426621089,0.0410645049500563,-0.0630985870400013,0.0978742723642192,0.671989332471249
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20716.Liking for salty foods,15242,0.0249007173698656,0.0388697747561864,-0.0512840411522598,0.101085475891991,0.521779878290861
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20717.Liking for salty pretzels,15242,-0.0358625958756161,0.0387636516861395,-0.11183935318045,0.0401141614292174,0.354897142755157
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20718.Liking for sardines,15242,0.0427268315816546,0.0391377029064781,-0.0339830661150426,0.119436729278352,0.274980005619973
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20719.Liking for sausages (meat),15242,0.0240124828676654,0.0388458807613508,-0.0521254434245821,0.100150409159913,0.536487384178184
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20720.Liking for savoury biscuits,15242,0.0474581364399956,0.039552850936312,-0.030065451395176,0.124981724275167,0.230209913230861
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),15242,0.00549796908109104,0.0394710559088303,-0.0718653005002164,0.0828612386623985,0.889221919831489
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20722.Liking for skimmed milk,15242,0.0534189429321919,0.0391815713226596,-0.023376936860221,0.130214822724605,0.17278638756143
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20723.Liking for smoked fish,15242,-0.0410723794814286,0.0393295708642357,-0.118158338375331,0.0360135794124734,0.296357218436455
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20724.Liking for soft cheese,15242,0.0336338089093782,0.0391529404927956,-0.0431059544565011,0.110373572275257,0.390333853154479
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20725.Liking for soy sauce,15242,-0.0187478702223889,0.0390152440374396,-0.0952177485357706,0.0577220080909927,0.630859761029307
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20726.Liking for soya milk,15242,0.0531764309429804,0.0393715964366314,-0.0239918980728172,0.130344759958778,0.176834298203008
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20727.Liking for spicy foods,15242,-0.0459426471495544,0.0394023662623876,-0.123171285023834,0.0312859907247253,0.24363797035873
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20728.Liking for spinach,15242,0.0098638341180331,0.0395866879703146,-0.0677260743037836,0.0874537425398498,0.803232274010334
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20729.Liking for spirits,15242,0.0471516208967356,0.0387258056052689,-0.0287509580895915,0.123054199883063,0.223403924691698
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20730.Liking for strawberries,15242,-0.0317730557353611,0.0424044834321629,-0.1148858432624,0.0513397317916781,0.45369685195443
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,15242,0.0513247757071551,0.039950387634568,-0.0269779840565981,0.129627535470908,0.198912205156787
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20732.Liking for sweet foods,15242,0.00787050514511791,0.0388375760248592,-0.0682511438636061,0.0839921541538419,0.839409899166139
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20733.Liking for taking the stairs,15242,0.0624615502255507,0.0399963597700607,-0.0159313149237682,0.14085441537487,0.118383978255679
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20734.Liking for tea with sugar,15242,-0.0292561755156877,0.0476004379138752,-0.122553033826883,0.0640406827955076,0.538814969766515
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20735.Liking for tea without sugar,15242,0.0489174506257701,0.0412566838222661,-0.0319456496658715,0.129780550917412,0.235765045759252
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20736.Liking for tomato ketchup,15242,0.078489836300637,0.03894074512051,0.00216597586443729,0.154813696736837,0.0438570230686417
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20737.Liking for tinned tuna,15242,0.051857058206241,0.0393290841250364,-0.0252279466788303,0.128942063091312,0.187342040433337
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20738.Liking for turnip (white),15242,0.0420770719306381,0.0386084870353406,-0.0335955626586294,0.117749706519906,0.275800904091216
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20739.Liking for vegetables,15242,0.072555757665229,0.0436016291089536,-0.01290343538832,0.158014950718778,0.0961208859302303
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20740.Liking for vinegar,15242,-0.0442877142173801,0.0392533311422186,-0.121224243256128,0.0326488148213683,0.259230596664319
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20741.Liking for watching television,15242,0.0319279192068171,0.0397628454355923,-0.0460072578469438,0.109863096260578,0.4220111958404
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20742.Liking for whisky,15242,0.0675592840433199,0.0401168413823201,-0.0110697250660274,0.146188293152667,0.0921900208201701
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20743.Liking for white bread,15242,0.00753076452311125,0.0390118385773834,-0.0689324390885603,0.0839939681347828,0.846931839605974
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20744.Liking for white rice,15242,0.0449216865637082,0.0389942823304148,-0.0315071068039047,0.121350479931321,0.249336288959889
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20745.Liking for white wine,15242,-0.0381823646588799,0.0391110825203785,-0.114840086398822,0.0384753570810619,0.328953950267816
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,15242,0.063271092488515,0.0396197199550088,-0.0143835586233022,0.140925743600332,0.110295472569824
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20747.Liking for whole milk,15242,0.0220564566782959,0.0389772161159262,-0.0543388869089196,0.0984518002655113,0.571483184641575
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20748.Liking for wholemeal bread,15242,0.0630080667498051,0.0409653780096938,-0.0172840741491947,0.143300207648805,0.124049617100293
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20749.Liking for working up a sweat,15242,0.0514728121057906,0.0390192525184179,-0.0250049228303085,0.12795054704189,0.187133975758027
LYZL2,Lysozyme-like protein 2,Physical measures,X21001.Body mass index (BMI),42971,0.0196549134180915,0.00788373418827781,0.00420279440906702,0.035107032427116,0.0126671616349762
LYZL2,Lysozyme-like protein 2,Physical measures,X21002.Weight,43002,-0.0143072615481656,0.00445174064052417,-0.023032673203593,-0.00558184989273825,0.00131061091818898
LYZL2,Lysozyme-like protein 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,14501,-0.000299831444388168,0.00326470469647204,-0.00669865264947337,0.00609898976069704,0.926826197904406
LYZL2,Lysozyme-like protein 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,14598,0.0132764897738827,0.0422630013187681,-0.0695589928109027,0.0961119723586681,0.753419375359657
LYZL2,Lysozyme-like protein 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,14612,-0.0108488834681967,0.043416621946734,-0.0959454624837954,0.074247695547402,0.802684771967369
LYZL2,Lysozyme-like protein 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,14614,0.0193807877634671,0.0427438302295588,-0.064397119486468,0.103158695013402,0.650255094452962
LYZL2,Lysozyme-like protein 2,Health and medical history,X21040.Satisfaction with bowel habits,14544,-0.00436794395695751,0.039585915116063,-0.0819563375844411,0.0732204496705261,0.912140577558155
LYZL2,Lysozyme-like protein 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,14524,0.02521796208726,0.0422148929202878,-0.0575232280365041,0.107959152211024,0.550268891657102
LYZL2,Lysozyme-like protein 2,Health and medical history,X21042.Greatest number of times bowels opened per day,14539,-0.0607674119792069,0.0427635691385009,-0.144584007490669,0.0230491835322549,0.155335643320503
LYZL2,Lysozyme-like protein 2,Health and medical history,X21043.Least number of times bowels opened per week,14429,0.0361190775455675,0.0425683290327223,-0.0473148473585683,0.119553002449703,0.396175619610217
LYZL2,Lysozyme-like protein 2,Health and medical history,X21044.Average number of times bowels opened per day,14493,-0.0318910323024713,0.0480840797399163,-0.126135828592707,0.0623537639877646,0.507190787462485
LYZL2,Lysozyme-like protein 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,14619,0.036701479041703,0.0432114342266643,-0.0479929320425589,0.121395890125965,0.395702453666059
LYZL2,Lysozyme-like protein 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,14609,0.0202611650025166,0.0433493965414913,-0.0647036522188064,0.10522598222384,0.640226359976371
LYZL2,Lysozyme-like protein 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,8233,0.0206704822714399,0.0673566336356677,-0.111348519654469,0.152689484197349,0.758941600389101
LYZL2,Lysozyme-like protein 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,14616,0.0583387575246308,0.0472846141345193,-0.034339086179027,0.151016601228289,0.217305176605892
LYZL2,Lysozyme-like protein 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,14612,0.0280460667021659,0.0657148280394603,-0.100754996255176,0.156847129659508,0.669542628161118
LYZL2,Lysozyme-like protein 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,14612,-0.0193720762523456,0.0509324514749444,-0.119199681143237,0.0804555286385454,0.703692349039995
LYZL2,Lysozyme-like protein 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,14611,0.015870685161745,0.127159398657309,-0.233361736206581,0.265103106530071,0.900676183474225
LYZL2,Lysozyme-like protein 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,14619,-0.0169897907128128,0.0494178345940587,-0.113848746517168,0.0798691650915423,0.731002575360153
LYZL2,Lysozyme-like protein 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,14615,0.0020788367843302,0.049280985441393,-0.0945118946808,0.0986695682494604,0.966353116768059
LYZL2,Lysozyme-like protein 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,14272,0.0425003304226208,0.0450109143952732,-0.0457210617921147,0.130721722637356,0.345071821888233
LYZL2,Lysozyme-like protein 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,14612,-0.0179756427671068,0.0442123030042238,-0.104631756655385,0.0686804711211718,0.684325696038662
LYZL2,Lysozyme-like protein 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,14615,0.0126359985503138,0.0643834459056292,-0.11355555542472,0.138827552525347,0.844408141766755
LYZL2,Lysozyme-like protein 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,14619,-0.00720383909512937,0.0431436858769843,-0.0917654634140186,0.0773577852237599,0.867393451477432
LYZL2,Lysozyme-like protein 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,14617,-0.0646422554643833,0.0433034042188345,-0.149516927733299,0.0202324168045324,0.135517600318621
LYZL2,Lysozyme-like protein 2,Working and living environment,X21100.Water hardness (USGS classification),42741,0.0651598297115225,0.0246873994712764,0.0167725267478208,0.113547132675224,0.00830839876626677
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2139.Age first had sexual intercourse,37261,0.00115107125766281,0.00203270192349027,-0.00283302451237811,0.00513516702770373,0.571209269111445
LYZL2,Lysozyme-like protein 2,Health and medical history,X2149.Lifetime number of sexual partners,34577,-0.0148147344209718,0.0280166509513823,-0.0697273702856812,0.0400979014437375,0.596959246934066
LYZL2,Lysozyme-like protein 2,Physical activities,X22032.IPAQ activity group,34548,-0.0585419162761429,0.0272908936560528,-0.112032067842006,-0.00505176471027936,0.0319511607823386
LYZL2,Lysozyme-like protein 2,Physical activities,X22033.Summed days activity,35458,-0.00436169674512485,0.00198770347526298,-0.00825759555664029,-0.000465797933609402,0.0282174596707179
LYZL2,Lysozyme-like protein 2,Physical activities,X22034.Summed minutes activity,34548,-0.00149516895965943,0.0020061994475335,-0.0054273198768251,0.00243698195750624,0.456110965012291
LYZL2,Lysozyme-like protein 2,Physical activities,X22037.MET minutes per week for walking,33063,-0.00254236164665607,0.00205404684177151,-0.00656829345652822,0.00148357016321608,0.215823856061838
LYZL2,Lysozyme-like protein 2,Physical activities,X22038.MET minutes per week for moderate activity,34548,-0.000583628492955262,0.0020089074452747,-0.00452108708569366,0.00335383009978314,0.771419929682711
LYZL2,Lysozyme-like protein 2,Physical activities,X22039.MET minutes per week for vigorous activity,34548,-0.0556041607095629,0.0272258877124364,-0.108966900625938,-0.00224142079318758,0.0411267024044274
LYZL2,Lysozyme-like protein 2,Physical activities,X22040.Summed MET minutes per week for all activity,33063,-0.0038959452786486,0.00205933914331358,-0.00793224999954323,0.00014035944224602,0.0585207048298463
LYZL2,Lysozyme-like protein 2,Eye measures,X2217.Age started wearing glasses or contact lenses,36687,0.00182720406415994,0.00197139640872998,-0.00203673289695081,0.0056911410252707,0.354006489190907
LYZL2,Lysozyme-like protein 2,Working and living environment,X22501.Year ended full time education,10217,-0.000621832362266422,0.00895373604526186,-0.0181711550109797,0.0169274902864468,0.944633201186784
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X22506.Tobacco smoking,10153,0.187055690414706,0.103159443608341,-0.0151368190576433,0.389248199887055,0.0698200984997322
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,40348,0.0287744037191118,0.0629694825808145,-0.0946457821392846,0.152194589577508,0.64770375330087
LYZL2,Lysozyme-like protein 2,Physical measures,X23098.Weight,42269,-0.0134052731282149,0.00448841968053218,-0.022202575702058,-0.0046079705543718,0.0028222763310203
LYZL2,Lysozyme-like protein 2,Physical measures,X23099.Body fat percentage,42240,0.00963522089814146,0.00430792356661914,0.00119169070756794,0.018078751088715,0.0253158866717718
LYZL2,Lysozyme-like protein 2,Physical measures,X23100.Whole body fat mass,42197,-0.000291923907264711,0.00416105043443835,-0.00844758275876388,0.00786373494423446,0.944069587794784
LYZL2,Lysozyme-like protein 2,Physical measures,X23101.Whole body fat-free mass,42264,-0.016787601871276,0.00374777956527031,-0.0241332498192058,-0.00944195392334623,7.50680581064209e-06
LYZL2,Lysozyme-like protein 2,Physical measures,X23102.Whole body water mass,42269,-0.0172252787203122,0.00375243251781712,-0.0245800464552337,-0.00987051098539059,4.43605706260511e-06
LYZL2,Lysozyme-like protein 2,Physical measures,X23104.Body mass index (BMI),42269,0.0232261882184393,0.00791767969879776,0.00770753600879565,0.0387448404280829,0.00335388034104075
LYZL2,Lysozyme-like protein 2,Physical measures,X23105.Basal metabolic rate,42267,-0.0173058312829597,0.00400940623098964,-0.0251642674956994,-0.00944739507021997,1.59021193028978e-05
LYZL2,Lysozyme-like protein 2,Physical measures,X23106.Impedance of whole body,42263,0.00690118844541998,0.00306893113243689,0.000886083425843683,0.0129162934649963,0.0245349980958202
LYZL2,Lysozyme-like protein 2,Physical measures,X23107.Impedance of leg (right),42266,0.00817105458174515,0.00251141028455908,0.00324869042400936,0.0130934187394809,0.00114053263196143
LYZL2,Lysozyme-like protein 2,Physical measures,X23108.Impedance of leg (left),42265,0.0072165277862955,0.00248680401976445,0.00234239190755719,0.0120906636650338,0.00371064559667395
LYZL2,Lysozyme-like protein 2,Physical measures,X23109.Impedance of arm (right),42258,0.000606736280937086,0.0030621972701962,-0.00539517036864746,0.00660864293052163,0.842938395796451
LYZL2,Lysozyme-like protein 2,Physical measures,X23110.Impedance of arm (left),42264,0.00212155433611867,0.00306205714693393,-0.00388007767187184,0.00812318634410918,0.488405850345345
LYZL2,Lysozyme-like protein 2,Physical measures,X23111.Leg fat percentage (right),42265,0.0179684432324665,0.00521669629815485,0.00774371848808303,0.0281931679768501,0.000572861370156867
LYZL2,Lysozyme-like protein 2,Physical measures,X23112.Leg fat mass (right),42264,-0.00248011172421044,0.0055433167336132,-0.0133450125220923,0.00838478907367143,0.654584425943615
LYZL2,Lysozyme-like protein 2,Physical measures,X23113.Leg fat-free mass (right),42263,-0.0212527408419678,0.00392610472744353,-0.0289479061077572,-0.0135575755761785,6.22491265321798e-08
LYZL2,Lysozyme-like protein 2,Physical measures,X23114.Leg predicted mass (right),42262,-0.0214250591160046,0.00394585775664823,-0.0291589403190351,-0.013691177912974,5.67403891935621e-08
LYZL2,Lysozyme-like protein 2,Physical measures,X23115.Leg fat percentage (left),42259,0.0159627132210737,0.00542110403388044,0.00533734931466802,0.0265880771274794,0.00323600574469687
LYZL2,Lysozyme-like protein 2,Physical measures,X23116.Leg fat mass (left),42259,-0.0049154894954196,0.00576870128060574,-0.0162221440054069,0.00639116501456765,0.394165429806122
LYZL2,Lysozyme-like protein 2,Physical measures,X23117.Leg fat-free mass (left),42256,-0.0207562445215156,0.00409378322836986,-0.0287800596491205,-0.0127324293939107,3.9910237404523e-07
LYZL2,Lysozyme-like protein 2,Physical measures,X23118.Leg predicted mass (left),42255,-0.0210581150559445,0.00411476682501406,-0.029123058032972,-0.0129931720789169,3.10647393398208e-07
LYZL2,Lysozyme-like protein 2,Physical measures,X23119.Arm fat percentage (right),42255,0.00437050434406283,0.00479036013288824,-0.00501860151639812,0.0137596102045238,0.361587590506718
LYZL2,Lysozyme-like protein 2,Physical measures,X23120.Arm fat mass (right),42252,-0.00626082292672901,0.00474524149037753,-0.015561496247869,0.00303985039441094,0.187046002525556
LYZL2,Lysozyme-like protein 2,Physical measures,X23121.Arm fat-free mass (right),42252,-0.0140892057559216,0.00377716989565582,-0.021492458751407,-0.00668595276043617,0.000191657186737204
LYZL2,Lysozyme-like protein 2,Physical measures,X23122.Arm predicted mass (right),42251,-0.0146167034399423,0.0037811789212495,-0.0220278141255914,-0.00720559275429333,0.000110960735793648
LYZL2,Lysozyme-like protein 2,Physical measures,X23123.Arm fat percentage (left),42247,0.00525359970738091,0.00490810519927449,-0.00436628648319709,0.0148734858979589,0.284448725593586
LYZL2,Lysozyme-like protein 2,Physical measures,X23124.Arm fat mass (left),42247,-0.00260425133805968,0.00473509188860752,-0.0118850314397304,0.00667652876361106,0.582329408923386
LYZL2,Lysozyme-like protein 2,Physical measures,X23125.Arm fat-free mass (left),42243,-0.0125687670036657,0.00384858422539617,-0.0201119920854421,-0.00502554192188917,0.00109236191643772
LYZL2,Lysozyme-like protein 2,Physical measures,X23126.Arm predicted mass (left),42240,-0.0127708692711356,0.00386268530117714,-0.0203417324614428,-0.00520000608082843,0.000946442368386225
LYZL2,Lysozyme-like protein 2,Physical measures,X23127.Trunk fat percentage,42238,0.0052956888029593,0.00308506954703003,-0.000751047509219561,0.0113424251151382,0.0860680080765663
LYZL2,Lysozyme-like protein 2,Physical measures,X23128.Trunk fat mass,42234,-0.000374833510469252,0.00339783876403521,-0.00703459748797826,0.00628493046703976,0.912159869512655
LYZL2,Lysozyme-like protein 2,Physical measures,X23129.Trunk fat-free mass,42228,-0.0122990728577371,0.00339952289445621,-0.0189621377308712,-0.00563600798460291,0.000297370168426962
LYZL2,Lysozyme-like protein 2,Physical measures,X23130.Trunk predicted mass,42223,-0.0119023849863517,0.00340374154919686,-0.0185737184227775,-0.00523105154992583,0.000471264216194032
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23400.Total Cholesterol,24016,0.00470468942629437,0.00248019262450754,-0.000156488117740402,0.00956586697032915,0.0578524897518258
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,24016,0.00726040292298365,0.00239900347826085,0.00255835610559238,0.0119624497403749,0.00247726812148467
LYZL2,Lysozyme-like protein 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",24016,0.00706876787697431,0.0024021817253131,0.00236049169536063,0.011777044058588,0.00325732669041554
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23403.VLDL Cholesterol,24016,0.0130344916345703,0.00240001368784242,0.00833046480639913,0.0177385184627414,5.65808257613581e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,24016,0.00455240196931073,0.00240095552440134,-0.000153470858515892,0.00925827479713736,0.0579615632091676
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23405.LDL Cholesterol,24016,0.00726747759349788,0.00239406401161808,0.00257511213072645,0.0119598430562693,0.00240295866431614
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23406.HDL Cholesterol,24016,-0.00850789056013231,0.00279320881449648,-0.0139825798365454,-0.00303320128371921,0.00232221184354643
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23407.Total Triglycerides,24016,0.0223969684989173,0.00253318939910826,0.0174319172766652,0.0273620197211695,1.00877680855182e-18
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23408.Triglycerides in VLDL,24016,0.022878370043861,0.00255144254160024,0.0178775426623245,0.0278791974253974,3.26899940445679e-19
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23409.Triglycerides in LDL,24016,0.0189850503877456,0.00246328674613826,0.0141570083653146,0.0238130924101766,1.33575501126629e-14
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23410.Triglycerides in HDL,24016,0.0161079330852807,0.00244023307153965,0.011325076265063,0.0208907899054984,4.16966761510913e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,24016,0.00819996242804867,0.00251654077856818,0.00326754250205504,0.0131323823540423,0.00112187747699418
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23412.Phospholipids in VLDL,24016,0.017745587602823,0.00245265952432405,0.0129383749351478,0.0225528002704981,4.78648503515781e-13
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23413.Phospholipids in LDL,24016,0.00715040296608294,0.00238906962579787,0.00246782649951912,0.0118329794326468,0.002765620695381
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23414.Phospholipids in HDL,24016,-0.00182021600885025,0.00268509587871602,-0.00708300393113365,0.00344257191343314,0.497844111221101
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23415.Total Esterified Cholesterol,24016,0.00410162936920638,0.0024932044440542,-0.000785051341139841,0.00898831007955261,0.0999574276286821
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,24016,0.0105581038875387,0.00238719886021543,0.00587919412151645,0.0152370136535609,9.78577821778263e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,24016,0.00890668178254947,0.00238883662377861,0.00422456199994339,0.0135888015651556,0.000193096146542636
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,24016,-0.00907814792784115,0.00278299681041368,-0.014532821676252,-0.00362347417943034,0.0011078182641702
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23419.Total Free Cholesterol,24016,0.00609568683293486,0.00244893807885619,0.00129576819837672,0.010895605467493,0.012812898838565
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,24016,0.0161165404666699,0.00243057571363387,0.0113526120679475,0.0208804688653923,3.41078381482107e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23421.Free Cholesterol in LDL,24016,0.00263604489274215,0.00241740560960602,-0.00210207010208565,0.00737415988756994,0.275528655659301
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23422.Free Cholesterol in HDL,24016,-0.00599136708973539,0.00278994929979903,-0.0114596677173415,-0.000523066462129293,0.0317648777557484
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,24016,0.0115387146073849,0.00242774681253564,0.00678033085481509,0.0162970983599548,2.01731427871726e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23424.Total Lipids in VLDL,24016,0.0197591031418001,0.00248227674529335,0.0148938407210251,0.024624365562575,1.7950251481117e-15
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23425.Total Lipids in LDL,24016,0.00818294343992278,0.00239115686775465,0.00349627597912367,0.0128696109007219,0.000622272176517619
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23426.Total Lipids in HDL,24016,-0.00332029491475181,0.00272659317177458,-0.00866441753143,0.00202382770192637,0.223332901949594
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,24016,0.00477277296119769,0.00256238302963324,-0.000249497776883466,0.00979504369927885,0.0625264683324204
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23428.Concentration of VLDL Particles,24016,0.0155789761854095,0.00241883644116281,0.0108380567607304,0.0203198956100886,1.21183316712766e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23429.Concentration of LDL Particles,24016,0.00846563579165504,0.00238113561910487,0.00379860997820948,0.0131326616051006,0.000378283324913121
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23430.Concentration of HDL Particles,24016,0.00350739572722693,0.0025695014430379,-0.00152882710112736,0.00854361855558122,0.172262632735153
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,24016,0.0240802520984918,0.002648597516379,0.018889000966389,0.0292715032305947,1.04856882597529e-19
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,24016,-0.00662281445640489,0.00248285523869467,-0.0114892107242464,-0.00175641818856333,0.00764876757198376
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,24016,-0.017521772300616,0.00283934145823903,-0.0230868815587645,-0.0119566630424675,6.89150668539288e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23434.Phosphoglycerides,23994,0.00875507300813996,0.00253158539182375,0.00379316564016541,0.0137169803761145,0.000544466265552144
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,23994,0.0224165986138827,0.00269204550292243,0.0171401894281547,0.0276930077996107,8.73130500753354e-17
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23436.Total Cholines,23994,0.00752829150495602,0.00255623205687229,0.00251807667348633,0.0125385063364257,0.00323187891258581
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23437.Phosphatidylcholines,23994,0.00706510027400553,0.00256466003628415,0.00203836660288861,0.0120918339451225,0.00587740678649818
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23438.Sphingomyelins,23993,0.00236105867323749,0.00257509019700503,-0.00268611811289237,0.00740823545936735,0.359212716749925
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23439.Apolipoprotein B,24016,0.00820575136332349,0.00238527797902089,0.00353060652444254,0.0128808962022044,0.000582346690542547
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23440.Apolipoprotein A1,24016,7.7692387251297e-05,0.0026537199532467,-0.00512359872111223,0.00527898349561482,0.976644085643172
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,24016,0.00718576752066326,0.00242786471458586,0.00242715268007498,0.0119443823612515,0.00308232813521971
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23442.Total Fatty Acids,23994,0.0171569873482258,0.0024294361300483,0.0123952925333311,0.0219186821631205,1.68447660236415e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23443.Degree of Unsaturation,23994,-0.0131346854301587,0.00260806328232881,-0.0182464894635232,-0.00802288139679428,4.78347563636904e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,23994,0.00717536859252211,0.00246766833633367,0.00233873865330811,0.0120119985317361,0.0036437011908947
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,23994,0.0120948299803714,0.00243456429775801,0.00732308395676574,0.0168665760039771,6.81244390272043e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,23994,0.0119623660367124,0.00244747633917628,0.00716531241192692,0.0167594196614979,1.02714483603859e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,23994,0.0210569211605285,0.00248351618461301,0.016189229438687,0.02592461288237,2.40717682302546e-17
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23448.Saturated Fatty Acids,23994,0.0161294710909496,0.00244101380072914,0.0113450840415205,0.0209138581403787,3.98538539459002e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23449.Linoleic Acid,23994,0.0119422376644511,0.00242411323810526,0.00719097571776476,0.0166934996111374,8.43006611381043e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23450.Docosahexaenoic Acid,23994,-0.000636890533471407,0.00253807958935227,-0.00561152652860185,0.00433774546165903,0.801867265739245
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,23994,-0.00159583790544162,0.00248133930560002,-0.00645926294441765,0.00326758713353441,0.520142197333801
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,23994,-0.0162604221520246,0.00258759599741466,-0.0213321103069574,-0.0111887339970919,3.35671873155006e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,23994,-0.018068638937974,0.00263254080730024,-0.0232284189202825,-0.0129088589556655,6.87953497446668e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,23994,0.0231897741970692,0.00268506407710926,0.017927048605935,0.0284524997882033,6.14665691768658e-18
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,23994,0.00398628846311162,0.00243164505590824,-0.000779735846468527,0.00875231277269176,0.101155976316166
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,23994,-0.00729408516134317,0.00258236956977674,-0.0123555295181056,-0.00223264080458077,0.00473830845634662
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,23994,-0.0116942337186324,0.00254225284835762,-0.0166770493014134,-0.0067114181358515,4.24754243292224e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,23994,-0.0220603887416446,0.00268185062348388,-0.0273168159636731,-0.0168039615196162,2.03624231658154e-16
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,23992,-0.00285950891763623,0.00245746852556588,-0.00767614722774536,0.00195712939247289,0.24459797068219
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23460.Alanine,24007,0.00782407195614631,0.00242099057537946,0.00307893042840258,0.01256921348389,0.00123194279961498
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23461.Glutamine,23937,-0.0103440389185415,0.00241049945153346,-0.015068617843547,-0.00561945999353587,1.78373492738155e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23462.Glycine,23986,0.00375573040522673,0.00253181686128613,-0.00120663064289408,0.00871809145334754,0.137977824620579
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23463.Histidine,23985,0.00268943375251566,0.00238605000675179,-0.00198722426071784,0.00736609176574917,0.259690794032438
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),23997,0.00656999379062343,0.00253188279059515,0.00160750352105694,0.0115324840601899,0.0094674824856448
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23465.Isoleucine,24011,0.00239417530216343,0.00247025951525052,-0.00244753334772759,0.00723588395205446,0.332455223639009
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23466.Leucine,24012,0.00620468507487195,0.00251987793959823,0.00126572431325941,0.0111436458364845,0.0138120474176601
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23467.Valine,23997,0.00741147191949764,0.00254082880367262,0.0024314474642993,0.012391496374696,0.00353799554945109
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23468.Phenylalanine,24006,0.00219252386182975,0.00240739460800951,-0.00252596956986888,0.00691101729352838,0.362438621908613
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23469.Tyrosine,23987,0.000598498418186609,0.0024643701270401,-0.00423166703081199,0.00542866386718521,0.808115462970173
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23470.Glucose,23974,-0.00610080135770184,0.00243751378152697,-0.0108783283694947,-0.00132327434590899,0.0123253787381583
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23471.Lactate,23974,0.0249371727582917,0.00241457349980358,0.0202046086986767,0.0296697368179068,5.95320607304881e-25
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23472.Pyruvate,23936,0.00806594352220364,0.00240116549716729,0.00335965914775574,0.0127722278966515,0.000782966092731142
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23473.Citrate,24013,0.00326693435686454,0.00243022748795213,-0.00149631151952164,0.00803018023325071,0.178866822787357
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23474.3-Hydroxybutyrate,23628,0.00375668917593551,0.00245318762594722,-0.00105155857092105,0.00856493692279207,0.125696279334085
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23475.Acetate,23996,-0.0116152955366874,0.00238766134850161,-0.0162951117797506,-0.00693547929362429,1.15347666454268e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23476.Acetoacetate,24015,-0.00496352807271104,0.00240721582878073,-0.00968167109712127,-0.000245385048300811,0.0392244472001512
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23477.Acetone,24015,-0.004797974548954,0.0024014092584703,-0.00950473669555579,-9.12124023522091e-05,0.0457297816250027
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23478.Creatinine,23428,0.0117514902496882,0.00289903116172511,0.00606938917270702,0.0174335913266694,5.06000290988849e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23479.Albumin,24012,0.00825986948479917,0.00242992590059441,0.00349721471963414,0.0130225242499642,0.000676865379209227
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23480.Glycoprotein Acetyls,24016,0.0214449279332489,0.00255481457050158,0.0164374913750658,0.026452364491432,4.95788800059394e-17
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,24016,0.0188488078902001,0.00256434318331196,0.0138226952509087,0.0238749205294916,2.04016492475308e-13
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,24016,0.0184149331339418,0.0025585722321575,0.0134001315589131,0.0234297347089705,6.32004015590799e-13
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,24016,0.0191443699320579,0.00257744099508829,0.0140925855816848,0.0241961542824309,1.14215705670966e-13
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,24016,0.019905289121552,0.00254870828488065,0.0149098208831859,0.0249007573599181,5.95413485299247e-15
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,24016,0.0203246146650069,0.00253629806184473,0.0153534704637913,0.0252957588662226,1.16531528908199e-15
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,24016,0.0195697201218857,0.00255228041865413,0.0145672505013236,0.0245721897424478,1.81959030608031e-14
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,24016,0.0169087982221015,0.00254900504097399,0.0119127483417925,0.0219048481024105,3.34816592958248e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,24016,0.0220693565991382,0.00257122587021458,0.0170297538935177,0.0271089593047588,9.77701115474345e-18
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,24016,0.0216815223057424,0.00256778238655332,0.0166486688280979,0.0267143757833869,3.24674826976236e-17
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,24016,0.0203825678221682,0.00255623984652169,0.0153723377229856,0.0253927979213507,1.60876447226913e-15
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,24016,0.0190388149123801,0.00250279488711716,0.0141333369336305,0.0239442928911297,2.90770620105707e-14
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,24016,0.0174343208227931,0.00246912271576165,0.0125948402999002,0.0222738013456859,1.6988949826681e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,24016,0.0200502021097502,0.0025348895318877,0.0150818186272503,0.0250185855922501,2.69086221898422e-15
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,24016,0.0224590045935775,0.00259166582934341,0.0173793395680644,0.0275386696190906,4.75922659331918e-18
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,24016,0.0220979348984422,0.00253990445932773,0.0171197221581599,0.0270761476387246,3.51865127625903e-18
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,24016,0.0218021877237726,0.00253384522152256,0.0168358510895884,0.0267685243579568,8.13476494182511e-18
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,24016,0.0216389967303523,0.00254905759918298,0.0166428438359537,0.026635149624751,2.20276309883232e-17
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,24016,0.0194976645764577,0.00248929837294076,0.0146186397654938,0.0243766893874216,4.97608180375481e-15
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,24016,0.0170833279517004,0.0024453044384974,0.0122905312522455,0.0218761246511553,2.8985734734164e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,24016,0.0215976100417527,0.00253724968959612,0.0166246006501443,0.0265706194333611,1.80486364148976e-17
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,24016,0.0223414772092497,0.00254174633835186,0.01735965438608,0.0273233000324193,1.59651431808371e-18
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,24016,0.0143616187750685,0.00239776352723954,0.00966200226167897,0.019061235288458,2.13365321406359e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,24016,0.0169788515077653,0.00241591983020931,0.012243648640555,0.0217140543749755,2.15267103907129e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,24016,0.0134618703176092,0.00239324935240587,0.00877110158689368,0.0181526390483247,1.87644064776975e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,24016,0.00575403253038368,0.00238888000892928,0.00107182771288229,0.0104362373478851,0.0160180897332356
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,24016,0.00147874391723414,0.00241222595970339,-0.00324921896378451,0.00620670679825279,0.539868606077477
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,24016,0.01090440162405,0.00238462870663257,0.00623052935905015,0.0155782738890498,4.83679452379038e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,24016,0.022840359030576,0.00249895274592731,0.0179424116485584,0.0277383064125935,6.72830395610311e-20
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,24016,0.0186528008936227,0.00244415521196842,0.0138622566781646,0.0234433451090808,2.40482070530481e-14
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,24016,0.0183583542445922,0.00243573220953476,0.013584319113904,0.0231323893752803,4.9752633000085e-14
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,24016,0.0143991665481704,0.00239804179309365,0.0096990046337068,0.0190993284626339,1.94618127981618e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,24016,0.0122562509261978,0.00239073200159938,0.00757041620306302,0.0169420856493326,2.97360303878689e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,24016,0.0130054672321432,0.00239952648431969,0.00830239532287657,0.0177085391414098,6.01682978073065e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,24016,0.0106735599524187,0.00238290295120076,0.00600307016806525,0.0153440497367722,7.52597811609568e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,24016,0.0224503171097799,0.00250619675736443,0.0175381714653456,0.0273624627542142,3.54337648623611e-19
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,24016,0.00706510443565466,0.0024161527790865,0.00232944498864513,0.0118007638826642,0.0034576189334675
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,24016,0.00729004982903864,0.00242226202244145,0.00254241626505339,0.0120376833930239,0.00261859961109337
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,24016,0.00779497836368413,0.00241639293834898,0.00305884820452013,0.0125311085228481,0.0012575700523264
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,24016,0.00107049643510567,0.00245547079838602,-0.00374222632973092,0.00588321919994226,0.662866898890042
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,24016,-0.000741660818568341,0.0024754268189969,-0.00559349738380227,0.00411017574666559,0.764477807853833
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,24016,0.00519038397359025,0.00242182384965374,0.000443609228268923,0.00993715871891158,0.0321093481505357
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,24016,0.0180101173485837,0.00246931748697806,0.0131702550741067,0.0228499796230607,3.11226204903568e-13
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23523.Concentration of IDL Particles,24016,0.00166904083301147,0.00241708903641359,-0.00306845367835916,0.0064065353443821,0.489875861830377
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23524.Total Lipids in IDL,24016,0.000980240737979728,0.00248087681986724,-0.00388227782896007,0.00584275930491952,0.692758825556646
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23525.Phospholipids in IDL,24016,0.000930892250665885,0.00248089726978055,-0.003931666398104,0.00579345089943577,0.707497182074924
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23526.Cholesterol in IDL,24016,-0.000962890344591056,0.00249149775362659,-0.00584622594169917,0.00392044525251706,0.699151683477412
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,24016,-0.000605130044230472,0.00249228526718233,-0.00549000916790785,0.0042797490794469,0.808161421372739
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23528.Free Cholesterol in IDL,24016,-0.00197950519978238,0.00248415753047979,-0.00684845395952277,0.00288944355995802,0.425545035607684
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23529.Triglycerides in IDL,24016,0.0157505604011045,0.00245054116363969,0.0109474997203708,0.0205536210818383,1.32259750954315e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,24016,0.00734680305491323,0.00238609771556845,0.00267005153239906,0.0120235545774274,0.00207928678194322
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23531.Total Lipids in Large LDL,24016,0.00629141202772773,0.00241021276044995,0.00156739501724583,0.0110154290382096,0.00905153479045892
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23532.Phospholipids in Large LDL,24016,0.00489819955273905,0.00240648313420481,0.000181492609697622,0.00961490649578047,0.0418197740701234
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23533.Cholesterol in Large LDL,24016,0.00549309972241279,0.00241583340364471,0.000758066251269144,0.0102281331935564,0.0229873594841058
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,24016,0.00691593781574062,0.00240715727484615,0.00219790955704217,0.0116339660744391,0.00406857012568935
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,24016,0.00149170551647672,0.00244333310823854,-0.00329722737567082,0.00628063840862426,0.541522695216051
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23536.Triglycerides in Large LDL,24016,0.0173038818811271,0.00245389479260017,0.0124942480876307,0.0221135156746234,1.81667570731425e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,24016,0.00971014435450814,0.00238158141859477,0.0050422447740624,0.0143780439349539,4.57313699281276e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,24016,0.0114340987371255,0.00238228546194474,0.00676481923171383,0.0161033782425372,1.59911649949608e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,24016,0.0110536591507538,0.00237958674529036,0.00638966912998466,0.0157176491715229,3.41546715732773e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,24016,0.0104442510239246,0.00238029389992615,0.00577887498006932,0.0151096270677798,1.14991504586754e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,24016,0.0122045149087721,0.00238631304304765,0.00752734134439874,0.0168816884731455,3.1719057959059e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,24016,0.00523449989806287,0.00238497522751077,0.000559948452141753,0.00990905134398398,0.0281888074931217
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,24016,0.0209033839555426,0.00247623889237888,0.01604995572648,0.0257568121846052,3.30516075836201e-17
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,24016,0.00985975500032024,0.00238087007732924,0.00519324964875492,0.0145262603518855,3.46613574256174e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23545.Total Lipids in Small LDL,24016,0.0101264873640333,0.00238139647988496,0.0054589502634588,0.0147940244646078,2.12356126944779e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23546.Phospholipids in Small LDL,24016,0.00735541655335028,0.00238120556800117,0.00268825364006798,0.0120225794666326,0.00201097002425809
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23547.Cholesterol in Small LDL,24016,0.0093348610747074,0.00237852323821396,0.00467295552780803,0.0139967666216068,8.70996193439248e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,24016,0.0116295441117374,0.00238369305945134,0.00695750571521282,0.0163015825082621,1.07420932207586e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,24016,0.00288485973638856,0.00238339227869184,-0.00178658912984744,0.00755630860262456,0.226137084048638
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23550.Triglycerides in Small LDL,24016,0.0222922160300702,0.00249886021425747,0.0173944500101256,0.0271899820500149,4.94556704929127e-19
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,24016,-0.0142230915554597,0.00279277278911982,-0.0196969262221345,-0.00874925688878484,3.55442788906851e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,24016,-0.0173830897435918,0.00280097585224752,-0.0228730024139969,-0.0118931770731866,5.52100654421207e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,24016,-0.0176266645263151,0.00279040429212296,-0.0230958569388761,-0.012157472113754,2.7156834103383e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,24016,-0.0187591942518104,0.00281041920380961,-0.0242676158912772,-0.0132507726123436,2.52839619327048e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,24016,-0.0185368170866999,0.00284445596860691,-0.0241119507851694,-0.0129616833882304,7.32361714975649e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,24016,-0.0179554703337272,0.00265935925561334,-0.0231678144747293,-0.012743126192725,1.49350214401005e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,24016,0.0124331374210657,0.00241262809171853,0.00770438636129739,0.017161888480834,2.57887787803662e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,24016,-0.0151952866627286,0.00289999501576203,-0.0208792768936222,-0.00951129643183507,1.62140627532835e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23559.Total Lipids in Large HDL,24016,-0.015102655279215,0.00287765322096731,-0.0207428555923109,-0.00946245496611906,1.54852202997272e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23560.Phospholipids in Large HDL,24016,-0.0137033980670488,0.0028422830015923,-0.0192742727501697,-0.00813252338392787,1.43523968070771e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23561.Cholesterol in Large HDL,24016,-0.017704668079743,0.00289981393322875,-0.0233883033888713,-0.0120210327706146,1.04084381135991e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,24016,-0.0180616387489132,0.00290026399187036,-0.0237461561729791,-0.0123771213248473,4.81537282071069e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,24016,-0.016128287861763,0.0028797140536963,-0.0217725274070077,-0.0104840483165182,2.15878994808864e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23564.Triglycerides in Large HDL,24016,0.00741482554655627,0.00246094954678195,0.00259136443486366,0.0122382866582489,0.00258953939943334
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,24016,-0.000172218254150213,0.00262691499143981,-0.00532097163737224,0.00497653512907181,0.94772937681525
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,24016,0.00141293601816366,0.00259285563833824,-0.00366906103297929,0.0064949330693066,0.585803755689906
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,24016,0.00299402264566804,0.00256120124751126,-0.00202593179945402,0.00801397709079011,0.242418640714601
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,24016,-0.00295905490907633,0.00264766198930593,-0.00814847240811596,0.0022303625899633,0.263744557518496
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,24016,-0.00333608402266919,0.00263790389363807,-0.00850637565419982,0.00183420760886143,0.206001097692256
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,24016,-0.00134950370944486,0.00267209697424155,-0.00658681377895831,0.00388780636006858,0.613538571284638
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,24016,0.0154253376664968,0.00244129357640825,0.0106404022567366,0.0202102730762569,2.68734360725956e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,24016,0.0123642731184299,0.00238397734237761,0.00769167752736974,0.01703686870949,2.16131660678059e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23573.Total Lipids in Small HDL,24016,0.0144815494745149,0.00240112085891775,0.00977535259103606,0.0191877463579937,1.65164907293867e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23574.Phospholipids in Small HDL,24016,0.0137717773618756,0.00241256348250176,0.00904315293617219,0.0185004017875791,1.15415651499215e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23575.Cholesterol in Small HDL,24016,0.0106773124310798,0.00238515590671832,0.00600240685391186,0.0153522180082477,7.62015378706772e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,24016,0.00939437549919158,0.00237414084003554,0.00474105945272193,0.0140476915456612,7.61285852668032e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,24016,0.012812306254353,0.00243271226018576,0.00804419022438893,0.0175804222843171,1.40113000625631e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23578.Triglycerides in Small HDL,24016,0.0220863025192555,0.00255801921806679,0.0170725848518446,0.0271000201866664,6.27844829593994e-18
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,22978,0.00506781450447521,0.00244518366981824,0.00027525451163146,0.00986037449731897,0.0382234384203751
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,22978,-0.00287053720510986,0.00247457134713168,-0.00772069704548796,0.00197962263526825,0.246055199394455
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,22978,0.000566704930757597,0.00245116524243176,-0.00423757894440866,0.00537098880592385,0.817162907501829
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,22978,-0.00674995586756079,0.00249601757565345,-0.0116421503158416,-0.00185776141928003,0.00685009096128539
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,22978,-0.000723994468534297,0.00243856654252664,-0.0055035848918865,0.00405559595481791,0.766550531328282
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,23756,-0.00027598004950215,0.00237690575144921,-0.0049347153223426,0.0043827552233383,0.907567171572082
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,23756,-0.015888619901229,0.00259944980607147,-0.0209835415211291,-0.0107936982813289,9.97346667640234e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,23756,-0.015534350418969,0.00259746570513675,-0.0206253832010371,-0.010443317636901,2.25525183714847e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,23756,-0.0135829905133379,0.00251734631408017,-0.0185169892889351,-0.0086489917377408,6.88879030279083e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,23756,0.0130359789199724,0.00253636395535966,0.00806470556746752,0.0180072522724774,2.77456721283534e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,24011,0.0138077203686786,0.00252650107746671,0.00885577825684383,0.0187596624805133,4.67103537167217e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,24011,-0.00977042384157464,0.00244116446531535,-0.0145551061935927,-0.00498574148955655,6.29016064582273e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,24011,-0.0143018792470117,0.0025296023162362,-0.0192598997868347,-0.00934385870718878,1.58716153720395e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,24011,0.00147704407305911,0.00239092464210208,-0.00320916822546097,0.00616325637157918,0.536732118879623
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,24011,0.00165775977474225,0.00236706229688288,-0.0029816823271482,0.0062972018766327,0.483718788823506
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,24016,-0.0123168985933898,0.00250213682530997,-0.0172210867709973,-0.00741271041578224,8.59892429499861e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,24016,-0.01926831,0.002608972,-0.02438189,-0.01415473,1.569444e-13
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,24016,-0.0201616604655514,0.00262709900070055,-0.0253107745069245,-0.0150125464241784,1.72380010280403e-14
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,24016,-0.0163090306805262,0.00254836074000456,-0.0213038177309352,-0.0113142436301173,1.58440544731357e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,24016,0.017944736576963,0.00258783676788801,0.0128725765119025,0.0230168966420235,4.1870386449267e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,24016,-0.0139312626010565,0.00254567414721769,-0.0189207839296031,-0.00894174127250977,4.48107292111911e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,24016,-0.0122728688865614,0.00246696671647407,-0.0171081236508506,-0.00743761412227222,6.57382502344852e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,24016,-0.00979098010002706,0.00240774618678329,-0.0145101626261223,-0.00507179757393182,4.78869071818386e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,24016,-0.0145087458387022,0.00256024243814645,-0.0195268210174692,-0.00949067065993514,1.47033987704986e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,24016,0.0129318383696072,0.00249177169248093,0.00804796585234454,0.0178157108868698,2.12213859322774e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,24016,0.00620758370776047,0.00249124876522445,0.00132473612792054,0.0110904312876004,0.0127180337247676
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,24016,-0.0176615214217915,0.00259605130104566,-0.022749781971841,-0.012573260871742,1.04707781136777e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,24016,-0.0180621351430693,0.00262202502503677,-0.0232013041921413,-0.0129229660939972,5.77276563442038e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,24016,-0.0109755060350667,0.00240644160111907,-0.01569213157326,-0.00625888049687328,5.11899586654458e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,24016,0.0185904560100608,0.00257624781515686,0.0135410102923534,0.0236399017277683,5.5090062165408e-13
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,24016,-0.000357628580680526,0.00238760447852856,-0.0050373333585965,0.00432207619723545,0.880935091602964
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,24016,-0.0115155173539408,0.00250492314557802,-0.0164251667192737,-0.00660586798860789,4.30483270846944e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,24016,-0.00850803496014545,0.0024957919755872,-0.0133997872322964,-0.00361628268799454,0.000653201400568004
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,24016,-0.0122228907898042,0.0024244245711521,-0.0169747629492624,-0.00747101863034611,4.65100981574268e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,24016,0.0146882010594892,0.00254998164091652,0.00969023704329281,0.0196861650756856,8.50804587930483e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,24016,-0.0111558162694337,0.00239450394578504,-0.0158490440031723,-0.00646258853569498,3.19568404764935e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,24016,-0.0059727581789102,0.00254439929969705,-0.0109597808063164,-0.000985735551503976,0.0189123217409497
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,24016,0.00977120050819618,0.00237525043270272,0.00511570966009884,0.0144266913562935,3.90570300768794e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,24016,-0.02128771480608,0.00261688836707111,-0.0264168160055394,-0.0161586136066206,4.32632242663958e-16
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,24016,0.0107469244459997,0.00250878202021636,0.00582971168637568,0.0156641372056238,1.84507218224679e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,24016,-0.00602520806869099,0.00239517493373941,-0.0107197509388202,-0.00133066519856174,0.0118907933277723
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,24016,-0.00586049921821737,0.00241893234362196,-0.0106016066117164,-0.00111939182471831,0.0154103322137848
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,24016,0.0127132681593802,0.00244240413415188,0.00792615605644251,0.0175003802623179,1.95354215787595e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,24016,-0.021198252593869,0.00259732367089928,-0.0262890069888316,-0.0161074981989064,3.46772062674743e-16
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,24016,0.00976353987684734,0.00245612214657849,0.00494954046955351,0.0145775392841412,7.0530361436965e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,24016,-0.0149278325422102,0.00240793149311134,-0.0196473782687085,-0.010208286815712,5.75866889621596e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,24016,0.000318959418867202,0.00239518780754733,-0.00437560868392556,0.00501352752165996,0.894062608470039
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,24016,0.0142811365444903,0.0024065093993498,0.00956437812176472,0.018997894967216,2.99009311261283e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,24016,-0.0162360490729636,0.00250745127361618,-0.0211506535692513,-0.0113214445766759,9.65682418486269e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,24016,0.0165433776527715,0.0025152818768881,0.0116134251740709,0.0214733301314722,4.89425631554731e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,24004,-0.0163024064234258,0.00267856743729274,-0.0215523986005196,-0.011052414246332,1.17345047192913e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,24004,0.00319036983841287,0.00250025847087678,-0.00171013676450562,0.00809087644133137,0.201962213369661
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,24004,-0.000896236707783665,0.00240901521187446,-0.00561790652305761,0.00382543310749028,0.709870467974316
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,24004,0.00992768761351238,0.0028337451631944,0.00437354709365136,0.0154818281333734,0.000460229033007636
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,24004,0.0242322076861131,0.00264921586275094,0.0190397445951213,0.029424670777105,6.31020858974692e-20
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,24016,0.0120832417224862,0.00264183393160406,0.00690524721654224,0.0172612362284302,4.8133116773523e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,24016,-0.0182509156144805,0.00271001398560959,-0.0235625430262753,-0.0129392882026857,1.6807053141692e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,24016,-0.016483139798648,0.00266700377721824,-0.0217104672019958,-0.0112558123953003,6.49701223699284e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,24016,-0.0137119966065409,0.0026130008731249,-0.0188334783178657,-0.00859051489521615,1.55397931178944e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,24016,0.0191090886916484,0.00261257279254191,0.0139884460182662,0.0242297313650305,2.66878197570538e-13
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,24016,0.0115003326817941,0.00267323743578368,0.00626078730765812,0.0167398780559301,1.69913487786875e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,24016,-0.0152556704425127,0.00262718751618259,-0.0204049579742306,-0.0101063829107948,6.44634397488291e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,24016,-0.0144032230061254,0.00255047166865253,-0.0194021474766844,-0.00940429853556646,1.64850492944747e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,24016,-0.00939468436649058,0.00280734902861059,-0.0148970884625673,-0.00389228027041383,0.000819757462364336
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,24016,0.016567549236775,0.00256440133430145,0.0115413226215441,0.0215937758520058,1.06293519562648e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,24016,-0.0038739508590357,0.00243560915415485,-0.0086477448011792,0.000899843083107811,0.111724727809662
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,24016,-0.00792930046494134,0.00243913886076081,-0.0127100126320325,-0.00314858829785015,0.00115214824921115
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,24016,-0.00697671469735266,0.00242028835816985,-0.0117204798793656,-0.00223294951533976,0.00394762341884095
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,24016,-0.00384083703362203,0.00256108505023894,-0.00886056373209036,0.0011788896648463,0.133707531177343
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,24016,0.0182647852369134,0.00260715155334266,0.0131547681923617,0.023374802281465,2.52338673814239e-12
LYZL2,Lysozyme-like protein 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,42534,-0.00216994185304927,0.00205728406857739,-0.00620221862746095,0.0018623349213624,0.291540894002507
LYZL2,Lysozyme-like protein 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,42534,-0.00210684540609584,0.00201099100470008,-0.00604838777530801,0.00183469696311632,0.294798815511628
LYZL2,Lysozyme-like protein 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,39519,-0.00131048429553335,0.00192947352900187,-0.00509225241237701,0.00247128382131032,0.497019764429139
LYZL2,Lysozyme-like protein 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,39519,-0.00139605001002063,0.00210634081978817,-0.00552447801680545,0.00273237799676419,0.507472460168036
LYZL2,Lysozyme-like protein 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,39519,-0.00210910460446313,0.00206936757761746,-0.00616506505659335,0.00194685584766709,0.308113082460618
LYZL2,Lysozyme-like protein 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,39519,-0.000685404224196773,0.0019030750639026,-0.00441543134944588,0.00304462290105233,0.718732275800143
LYZL2,Lysozyme-like protein 2,Working and living environment,X24009.Traffic intensity on the nearest road,42534,0.0348571119824394,0.0532822851518533,-0.0695761669151931,0.139290390880072,0.512988421712243
LYZL2,Lysozyme-like protein 2,Working and living environment,X24010.Inverse distance to the nearest road,42534,-0.00118290509160789,0.00180610663447278,-0.00472287409517454,0.00235706391195876,0.512505075468001
LYZL2,Lysozyme-like protein 2,Working and living environment,X24011.Traffic intensity on the nearest major road,42534,0.00176824049595631,0.00179864415451255,-0.00175710204688829,0.0052935830388009,0.325565616272935
LYZL2,Lysozyme-like protein 2,Working and living environment,X24012.Inverse distance to the nearest major road,42534,-0.00120273650882017,0.00183516133879192,-0.00479965273285233,0.002394179715212,0.512223699683092
LYZL2,Lysozyme-like protein 2,Working and living environment,X24013.Total traffic load on major roads,42534,0.0168109649484661,0.0374795368195912,-0.0566489272179327,0.0902708571148649,0.653767860712906
LYZL2,Lysozyme-like protein 2,Working and living environment,X24015.Sum of road length of major roads within 100m,42534,-0.00337680755627319,0.0366146326472912,-0.0751414875449638,0.0683878724324175,0.92651920966206
LYZL2,Lysozyme-like protein 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,42534,-0.00375144567500507,0.00205834359634345,-0.00778579912383824,0.000282907773828097,0.0683777433201019
LYZL2,Lysozyme-like protein 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,42534,-0.00433960312357347,0.00205612793686911,-0.00836961387983693,-0.000309592367310018,0.0348150622577213
LYZL2,Lysozyme-like protein 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,42534,-0.00345812481487286,0.00203460688569267,-0.0074459543108305,0.000529704681084776,0.0892036106124834
LYZL2,Lysozyme-like protein 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,42442,-0.000708925577399125,0.00199384456351738,-0.00461686092189319,0.00319900976709494,0.722174048622544
LYZL2,Lysozyme-like protein 2,Working and living environment,X24020.Average daytime sound level of noise pollution,42534,3.42634564329993e-05,0.00180757146369293,-0.00350857661240514,0.00357710352527114,0.984876678129839
LYZL2,Lysozyme-like protein 2,Working and living environment,X24021.Average evening sound level of noise pollution,42534,3.31867790424942e-05,0.00180770272043601,-0.00350991055301208,0.00357628411109707,0.985352914903497
LYZL2,Lysozyme-like protein 2,Working and living environment,X24022.Average night-time sound level of noise pollution,42534,2.28276398768175e-05,0.00180754546589473,-0.00351996147327686,0.0035656167530305,0.989923777570433
LYZL2,Lysozyme-like protein 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,42534,2.23459016108404e-05,0.00180763408545317,-0.00352061690587737,0.00356530870909905,0.990136891587437
LYZL2,Lysozyme-like protein 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,42534,3.37179663388505e-05,0.00180769418324877,-0.00350936263282874,0.00357679856550644,0.985118430487838
LYZL2,Lysozyme-like protein 2,Health and medical history,X2405.Number of children fathered,19528,0.222656917816452,0.0422329009320958,0.139880431989544,0.305433403643359,1.36292654230512e-07
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",37681,0.0038715392153963,0.00211568323432804,-0.000275199923886668,0.00801827835467926,0.0672692249250311
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",37681,-0.00251085413713664,0.0019152787014863,-0.0062648003920498,0.00124309211777651,0.189879204696353
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24502.Water percentage, buffer 1000m",37681,0.000986903725458014,0.00190173179811784,-0.00274049059885296,0.00471429804976899,0.603798654637628
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",37681,0.00255108688793384,0.00198962454725932,-0.00134857722469444,0.00645075100056211,0.199782098326153
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",37681,-0.00191210214491074,0.00193539279978179,-0.00570547203248304,0.00188126774266157,0.323175680965284
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24505.Water percentage, buffer 300m",37681,0.000464174553428502,0.00191716866474119,-0.00329347602946424,0.00422182513632124,0.808692671913811
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",42742,0.00212185573599512,0.00202078746147857,-0.00183888768850288,0.00608259916049313,0.293717475914565
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",42742,0.001118873904277,0.00190233247432354,-0.00260969774539714,0.00484744555395114,0.55642870466731
LYZL2,Lysozyme-like protein 2,Working and living environment,X24508.Distance (Euclidean) to coast,42742,0.00180155750787632,0.00180494355645851,-0.00173613186278237,0.005339246878535,0.318224879130357
LYZL2,Lysozyme-like protein 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,9446,-0.0496385434932449,0.0566370014522025,-0.160647066339562,0.061369979353072,0.380816943952121
LYZL2,Lysozyme-like protein 2,Health and medical history,X2704.Years since last cervical smear test,17714,-0.00897527838366307,0.040239778218769,-0.0878452436924502,0.0698946869251241,0.823503114483515
LYZL2,Lysozyme-like protein 2,Health and medical history,X2714.Age when periods started (menarche),22570,0.0455072057860069,0.0338339774374484,-0.020807389991392,0.111821801563406,0.178633926591823
LYZL2,Lysozyme-like protein 2,Health and medical history,X2734.Number of live births,23276,-0.0718325809149682,0.0321702790752373,-0.134886327902433,-0.00877883392750306,0.0255659101480658
LYZL2,Lysozyme-like protein 2,Health and medical history,X2744.Birth weight of first child,18481,-0.0795246113637277,0.0362507792900801,-0.150576138772285,-0.00847308395517064,0.028266873109019
LYZL2,Lysozyme-like protein 2,Health and medical history,X2754.Age at first live birth,15745,-0.000461484347816047,0.00313951021759287,-0.00661492437429807,0.00569195567866597,0.88313985082422
LYZL2,Lysozyme-like protein 2,Health and medical history,X2764.Age at last live birth,15698,-0.000859227236295234,0.00302169403466465,-0.00678174754423794,0.00506329307164747,0.77614376096609
LYZL2,Lysozyme-like protein 2,Health and medical history,X2794.Age started oral contraceptive pill,17814,-0.00333025794684947,0.00337979548533877,-0.00995465709811345,0.00329414120441452,0.324468992056229
LYZL2,Lysozyme-like protein 2,Health and medical history,X2804.Age when last used oral contraceptive pill,16152,-0.00239376254183967,0.00295480119720979,-0.00818517288837086,0.00339764780469153,0.417879460750115
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2867.Age started smoking in former smokers,10562,0.0022087580280168,0.00360240673792824,-0.00485195917832255,0.00926947523435615,0.539800964810126
LYZL2,Lysozyme-like protein 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",16045,-0.00531589499313312,0.0490813414762674,-0.101515324286617,0.090883534300351,0.913752844668738
LYZL2,Lysozyme-like protein 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,16038,0.015457816468339,0.053998490155236,-0.0903792242359234,0.121294857172601,0.774679733636762
LYZL2,Lysozyme-like protein 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,16066,0.0282875183410467,0.0554628442324457,-0.0804196563545469,0.13699469303664,0.610039934790309
LYZL2,Lysozyme-like protein 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",16014,0.0231618179129357,0.0541880406937614,-0.0830467418468367,0.129370377672708,0.669068907225805
LYZL2,Lysozyme-like protein 2,Mental health,X28739.Difficulty with standing for long periods,16084,0.00157546301690219,0.0478698849023653,-0.0922495113917338,0.0954004374255382,0.973745682516715
LYZL2,Lysozyme-like protein 2,Mental health,X28740.Difficulty with taking care of household responsibilities,16123,-0.0113547584654462,0.0534240257964776,-0.116065849026542,0.0933563320956498,0.831688230827918
LYZL2,Lysozyme-like protein 2,Mental health,X28741.Difficulty learning a new task,15990,0.0251957859420249,0.0596176216848006,-0.0916547525601843,0.142046324444234,0.672575936280354
LYZL2,Lysozyme-like protein 2,Mental health,X28742.Difficulty with joining in community activities,15398,0.0577565241340748,0.0598725073519997,-0.0595935902758446,0.175106638543994,0.334731045734536
LYZL2,Lysozyme-like protein 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,16021,-0.0179563411385931,0.0514552919444435,-0.118808713349702,0.0828960310725163,0.727116599304701
LYZL2,Lysozyme-like protein 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,16122,0.0961646514490662,0.0709596228193341,-0.0429162092768286,0.235245512174961,0.175372085484769
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,10049,-0.0512907916641122,0.0541567900513371,-0.157438100164733,0.0548565168365085,0.343621020298192
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2897.Age stopped smoking,10561,-0.00252788230430489,0.00377135583787774,-0.00991973974654526,0.00486397513793549,0.502690962401654
LYZL2,Lysozyme-like protein 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,14345,-0.00669078796197178,0.0064780651241559,-0.0193877956053173,0.00600621968137377,0.301697425590069
LYZL2,Lysozyme-like protein 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,14345,0.00510253395435434,0.00703946265243406,-0.00869481284441641,0.0188998807531251,0.468557683019203
LYZL2,Lysozyme-like protein 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,14345,0.0331882156651594,0.0236096838392806,-0.0130867646598305,0.0794631959901494,0.159833860491975
LYZL2,Lysozyme-like protein 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,14345,0.00374512016052215,0.0246845251652472,-0.0446365491633623,0.0521267894844067,0.879410428874173
LYZL2,Lysozyme-like protein 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,14345,0.0154512001332278,0.0269220562272926,-0.0373160300722657,0.0682184303387213,0.566028591999434
LYZL2,Lysozyme-like protein 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,14345,0.0115694579018506,0.0227160727513162,-0.0329540446907291,0.0560929604944303,0.610544800165335
LYZL2,Lysozyme-like protein 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,14345,-0.00369300499329381,0.0102272247479923,-0.0237383654993586,0.016352355512771,0.718033368220289
LYZL2,Lysozyme-like protein 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,14345,0.0384224369456055,0.018242767393646,0.00266661285405941,0.0741782610371516,0.0352066101878453
LYZL2,Lysozyme-like protein 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,14260,0.0315576576051326,0.0561606929051447,-0.078517300488951,0.141632615699216,0.574181296397731
LYZL2,Lysozyme-like protein 2,Mental health,X29003.Recent feelings of depression,14249,0.0153529318013236,0.054556030961357,-0.0915768888829361,0.122282752485583,0.778395553958529
LYZL2,Lysozyme-like protein 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",14268,0.0243110503562569,0.0439724177277294,-0.0618748883900928,0.110496989102607,0.580360794745227
LYZL2,Lysozyme-like protein 2,Mental health,X29005.Recent feelings of tiredness or low energy,14277,0.027658341924996,0.0446674679326955,-0.0598898952230872,0.115206579073079,0.535790878754214
LYZL2,Lysozyme-like protein 2,Mental health,X29006.Recent poor appetite or overeating,14291,0.0281331760621217,0.0615555069066987,-0.0925156174750078,0.148781969599251,0.647651034050187
LYZL2,Lysozyme-like protein 2,Mental health,X29007.Recent feelings of inadequacy,14230,-0.037896950498985,0.0600116248423366,-0.155519735189965,0.0797258341919947,0.527728058613981
LYZL2,Lysozyme-like protein 2,Mental health,X29008.Recent trouble concentrating on things,14288,-0.0279770727472954,0.0596244529835088,-0.144841000594973,0.088886855100382,0.638918516987504
LYZL2,Lysozyme-like protein 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,14272,-0.102707658354733,0.106917660739778,-0.312266273404698,0.106850956695233,0.336757608196134
LYZL2,Lysozyme-like protein 2,Mental health,X29010.Recent thoughts of suicide or self-harm,14201,-0.197974748288996,0.119839685932325,-0.432860532716353,0.0369110361383616,0.0985573864347595
LYZL2,Lysozyme-like protein 2,Mental health,X29038#0.Substances taken for depression_None of options listed,13506,0.0284062367729358,0.0126654516469919,0.00358195154483173,0.0532305220010398,0.0249250588322014
LYZL2,Lysozyme-like protein 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),13506,-0.0216498149591561,0.0241720361274329,-0.0690270057689246,0.0257273758506124,0.37045281029869
LYZL2,Lysozyme-like protein 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),13506,-0.00314770118292798,0.0126412002996066,-0.027924453770157,0.021629051404301,0.80336198276026
LYZL2,Lysozyme-like protein 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),13506,0.00251739159375208,0.0375444732230229,-0.0710697759233728,0.0761045591108769,0.946542156983451
LYZL2,Lysozyme-like protein 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),13506,-0.00755519269805894,0.0236654138816051,-0.0539394039060049,0.038829018509887,0.749541588553842
LYZL2,Lysozyme-like protein 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),13506,0.00928674774282602,0.0256422466007597,-0.0409720555946631,0.0595455510803151,0.717233719979692
LYZL2,Lysozyme-like protein 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),13506,0.0184864315594187,0.0293138392638753,-0.0389686933977769,0.0759415565166144,0.528287691637485
LYZL2,Lysozyme-like protein 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),13506,0.017319962090851,0.0326764487340799,-0.0467258774279457,0.0813658016096476,0.596090008891924
LYZL2,Lysozyme-like protein 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),13506,-0.0200161345625262,0.0243995847257131,-0.0678393206249239,0.0278070514998714,0.412032615840083
LYZL2,Lysozyme-like protein 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,13506,0.0124378629654768,0.0124091539161445,-0.0118840787101663,0.03675980464112,0.316210161555324
LYZL2,Lysozyme-like protein 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,13506,0.00869273138871567,0.0192897126196337,-0.0291151053457664,0.0465005681231977,0.652255702466323
LYZL2,Lysozyme-like protein 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,13506,-0.0295042766130731,0.0303715400822235,-0.0890324951742312,0.0300239419480849,0.331344211809856
LYZL2,Lysozyme-like protein 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,13506,0.0635540883012412,0.0381195063998367,-0.0111601442424387,0.138268320844921,0.0954913480185982
LYZL2,Lysozyme-like protein 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,13506,0.0336520290601146,0.0252027974433293,-0.0157454539288109,0.08304951204904,0.181817145084743
LYZL2,Lysozyme-like protein 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,13506,0.0108786794459323,0.0389390322720566,-0.0654418238072985,0.0871991826991632,0.779959616561842
LYZL2,Lysozyme-like protein 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,13506,0.00160292951929032,0.03718083788938,-0.0712715127438946,0.0744773717824752,0.965613122315592
LYZL2,Lysozyme-like protein 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,13506,0.000681143091819532,0.0207332778998047,-0.0399560815917977,0.0413183677754368,0.973792579351776
LYZL2,Lysozyme-like protein 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,13506,-0.00194416732809033,0.0203740297652954,-0.0418772656680692,0.0379889310118886,0.923979630339293
LYZL2,Lysozyme-like protein 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,13506,0.0462052038094046,0.0290076711119887,-0.0106498315700932,0.103060239188902,0.111214680428545
LYZL2,Lysozyme-like protein 2,Mental health,X29058.Recent feelings or nervousness or anxiety,14054,-0.0175944370056548,0.0518249549929303,-0.119171348791798,0.0839824747804885,0.734240140955538
LYZL2,Lysozyme-like protein 2,Mental health,X29059.Recent inability to stop or control worrying,14067,0.0249391305560607,0.0538469423266588,-0.0806008764041906,0.130479137516312,0.643265101112482
LYZL2,Lysozyme-like protein 2,Mental health,X29060.Recent worrying too much about different things,14060,0.0219996367480341,0.0495167848961817,-0.0750532616484821,0.11905253514455,0.6568423397354
LYZL2,Lysozyme-like protein 2,Mental health,X29061.Recent trouble relaxing,14065,-0.0064255715936752,0.0528072498031933,-0.109927781207934,0.0970766380205837,0.903154411888394
LYZL2,Lysozyme-like protein 2,Mental health,X29062.Recent restlessness,14079,0.0207584640960677,0.0745617748715525,-0.125382614652175,0.166899542844311,0.780704615936653
LYZL2,Lysozyme-like protein 2,Mental health,X29063.Recent easy annoyance or irritability,14038,-0.0118617905945344,0.053505529821621,-0.116732629044912,0.0930090478558429,0.824556265636717
LYZL2,Lysozyme-like protein 2,Mental health,X29064.Recent feelings of foreboding,14035,-0.0225356644515386,0.0609464320488504,-0.141990671267285,0.0969193423642083,0.711565540674935
LYZL2,Lysozyme-like protein 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,13506,-0.00200606517211418,0.0134324323178064,-0.0283336325150147,0.0243215021707864,0.881283724840881
LYZL2,Lysozyme-like protein 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,13506,0.0225493128547922,0.0218568256677853,-0.0202900654540671,0.0653886911636514,0.302239192848586
LYZL2,Lysozyme-like protein 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',13506,-0.0334597434664444,0.0289245743954679,-0.0901519092815616,0.0232324223486728,0.247377447581966
LYZL2,Lysozyme-like protein 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,13506,0.0163929196069651,0.0308646138158231,-0.0441017234720482,0.0768875626859783,0.59534199075062
LYZL2,Lysozyme-like protein 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,13506,-0.00893457391110943,0.0202704948809464,-0.0486647438777643,0.0307955960555454,0.659388437645585
LYZL2,Lysozyme-like protein 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,13506,0.00383225087099478,0.021863946571712,-0.0390210844095607,0.0466855861515502,0.860864473145337
LYZL2,Lysozyme-like protein 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,13506,0.0249536095055757,0.0217893779340574,-0.0177535712451768,0.0676607902563281,0.252138765265718
LYZL2,Lysozyme-like protein 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,13506,-0.00137519434243808,0.0206881764762024,-0.0419240202357948,0.0391736315509187,0.947002654028871
LYZL2,Lysozyme-like protein 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,13506,0.0225928706731913,0.026690315436097,-0.0297201475815589,0.0749058889279414,0.397298943520341
LYZL2,Lysozyme-like protein 2,Mental health,X29076.Felt loved as a child,14012,0.0642566851041016,0.0464486384875137,-0.0267826463314253,0.155296016539629,0.166566701165048
LYZL2,Lysozyme-like protein 2,Mental health,X29077.Physically abused by family as a child,14035,-0.137193245790201,0.0636229666351795,-0.261894260395153,-0.0124922311852491,0.0310734696218669
LYZL2,Lysozyme-like protein 2,Mental health,X29078.Felt hated by family member as a child,14007,-0.0416330126776494,0.0636763063576837,-0.16643857313871,0.0831725477834108,0.513236805225693
LYZL2,Lysozyme-like protein 2,Mental health,X29079.Sexually molested as a child,13909,0.0185799913914624,0.0841984346097132,-0.146448940443575,0.1836089232265,0.825353348745788
LYZL2,Lysozyme-like protein 2,Mental health,X29080.Someone to take to doctor when needed as a child,13987,0.0335675556586468,0.0675043715061756,-0.0987410124934573,0.165876123810751,0.619010074529176
LYZL2,Lysozyme-like protein 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,14009,-0.0703517378895176,0.0893228555719524,-0.245424534810544,0.104721059031509,0.430937131489476
LYZL2,Lysozyme-like protein 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,13931,-0.0462104371460477,0.0691415268690784,-0.181727829809441,0.089306955517346,0.503924079544181
LYZL2,Lysozyme-like protein 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,14021,-0.138081847921383,0.0784126483534868,-0.291770638694217,0.0156069428514515,0.0782663217510626
LYZL2,Lysozyme-like protein 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,13977,-0.112689311544212,0.110944228041048,-0.330139998504666,0.104761375416243,0.309775875804617
LYZL2,Lysozyme-like protein 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,13976,-0.0298849327332978,0.104031776768419,-0.2337872151994,0.174017349732804,0.773911884617027
LYZL2,Lysozyme-like protein 2,Mental health,X29086.Experienced a violent or sexual assault,14024,-0.00716359826649013,0.0866135300219265,-0.176926117109466,0.162598920576486,0.934085213475948
LYZL2,Lysozyme-like protein 2,Mental health,X29087.Experienced a life-threatening injury or illness,14028,0.0468713765377378,0.0537641645452015,-0.0585063859708571,0.152249139046333,0.3833346848911
LYZL2,Lysozyme-like protein 2,Mental health,X29088.Experienced a marital separation or divorce,14030,0.0458232311887187,0.0503226572281034,-0.0528091769783639,0.144455639355801,0.362527911074079
LYZL2,Lysozyme-like protein 2,Mental health,X29089.Experienced the death of a spouse or partner,14048,-0.129481652337101,0.0705778012856791,-0.267814142857032,0.00885083818282967,0.0665869388653093
LYZL2,Lysozyme-like protein 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,14028,-0.116034488828488,0.064849956120839,-0.243140402825333,0.0110714251683562,0.073591919847239
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29091.Frequency of drinking alcohol,14030,-0.0642123443111196,0.04177405285323,-0.14608948790345,0.0176647992812112,0.124282915996375
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,12483,-0.0851981638100106,0.0490093783409034,-0.181256545358181,0.0108602177381601,0.0821641108021598
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,12514,-0.0866076130618468,0.0490223083519723,-0.182691337431712,0.00947611130801883,0.0773032282861806
LYZL2,Lysozyme-like protein 2,Mental health,X29104.Ever used cannabis,14021,-0.00842682373249868,0.0598652803966432,-0.125762773309919,0.108909125844922,0.888059102337321
LYZL2,Lysozyme-like protein 2,Mental health,X29108.Ever thought that life not worth living,13958,-0.0667322942284334,0.0532561879261684,-0.171114422563724,0.0376498341068568,0.210211066087396
LYZL2,Lysozyme-like protein 2,Mental health,X29109.Ever contemplated self-harm,13987,-0.0109095690961585,0.0714148389139843,-0.150882653367568,0.129063515175251,0.878587117141878
LYZL2,Lysozyme-like protein 2,Mental health,X29111.Ever self-harmed,14014,-0.0841535837939417,0.117302943962797,-0.314067353961023,0.14576018637314,0.473136913938718
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,14008,0.060024912402789,0.0750418093338431,-0.0870570338915434,0.207106858697121,0.42379027622635
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,14559,0.049634087561805,0.0281821196206509,-0.0056028668946707,0.104871042018281,0.0782271369357354
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,14559,0.0320322641212623,0.0222495397603081,-0.0115768338089415,0.0756413620514661,0.149978881161678
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,14559,0.0398060488475198,0.023636397760515,-0.00652129076308964,0.0861333884581293,0.092183871485092
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,14559,0.0273777987144384,0.0322263505752251,-0.0357858484130028,0.0905414458418795,0.395590984452894
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,13990,-0.083397100092946,0.0475586042412305,-0.176611964405758,0.00981776421986581,0.0795270067698042
LYZL2,Lysozyme-like protein 2,Health and medical history,X29153.Pain or discomfort today,14014,0.058307919280502,0.0446074643427945,-0.0291227108313752,0.145738549392379,0.191188785109115
LYZL2,Lysozyme-like protein 2,Mental health,X29154.Anxiety or depression today,14014,0.0287561519119346,0.0551312849257681,-0.0793011665425708,0.13681347036644,0.601961237966506
LYZL2,Lysozyme-like protein 2,Mental health,X29166.Frequency of confiding in someone close,13665,0.0546613594559973,0.0432033101213256,-0.0300171283818009,0.139339847293795,0.205816835840019
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,13970,0.0166060962993846,0.00657332752423729,0.0037223743518795,0.0294898182468897,0.0115385692945944
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,13970,3.67501674181551e-05,0.00661298181443727,-0.0129246941888789,0.0129981945237152,0.995566037255783
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,13970,-0.0129937379053131,0.00827002500733545,-0.0292029869196905,0.00321551110906442,0.116162390362128
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,13970,-0.0160716426250624,0.00883977091094648,-0.0333975936105175,0.00125430836039267,0.0690693250775435
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,13970,-0.00278540936082997,0.0142103197749721,-0.0306376361197753,0.0250668173981153,0.844602737242982
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,13970,-0.01863524301096,0.00677508955888979,-0.031914418546384,-0.00535606747553603,0.00595714269220026
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,13963,-0.000450292194497811,0.00735196262781813,-0.0148601389450213,0.0139595545560257,0.951162668480012
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,13963,0.00404567918509154,0.0107699653125708,-0.0170634528275472,0.0251548111977303,0.707186849883737
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,13963,0.000601357267386544,0.016745375533097,-0.0322195787774837,0.0334222933122567,0.971353167893741
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,13963,-0.00888992599601454,0.0148232701136341,-0.0379435354187373,0.0201636834267083,0.548697452090639
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,13963,0.00803091947286803,0.0219660030166566,-0.0350224464397789,0.051084285385515,0.714664064389126
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,13963,-0.00917686319355374,0.0104817661418082,-0.0297211248314978,0.0113673984443903,0.381312993308713
LYZL2,Lysozyme-like protein 2,Mental health,X29171.Frequency of feeling 'in tune' with people,13724,-0.0469655587079492,0.0535607501953161,-0.151944629090769,0.0580135116748704,0.380575217381416
LYZL2,Lysozyme-like protein 2,Mental health,X29172.Freuency of feeling that lacks companionship,13909,-0.0353299922796739,0.0495642140935438,-0.13247585190302,0.0618158673436721,0.475973748785528
LYZL2,Lysozyme-like protein 2,Mental health,X29173.Frequency of feeling left out,13831,-0.0215937957240696,0.0511661415485293,-0.121879433159187,0.0786918417110478,0.673007561386564
LYZL2,Lysozyme-like protein 2,Mental health,X29174.Frequency of feeling isolated from others,13886,-0.0370584783896071,0.0530141487055104,-0.140966209852407,0.0668492530731933,0.4845450265041
LYZL2,Lysozyme-like protein 2,Mental health,X29175.Tendency to bounce back quickly after hard times,13995,-0.0654477639622018,0.0436347428372261,-0.150971859923165,0.0200763319987614,0.133662814647927
LYZL2,Lysozyme-like protein 2,Mental health,X29176.Ability to make it through stressful events,13995,-0.0252276442458299,0.0424556111659418,-0.108440642131076,0.057985353639416,0.552379777013613
LYZL2,Lysozyme-like protein 2,Mental health,X29177.Quick recovery from stressful events,13995,0.0529536783510494,0.0435969599795626,-0.0324963632088933,0.138403719910992,0.224532110804703
LYZL2,Lysozyme-like protein 2,Mental health,X29178.Hard to snap back when something bad happens,13995,-0.0479914265582741,0.0424583054002495,-0.131209705142763,0.0352268520262149,0.258361252985723
LYZL2,Lysozyme-like protein 2,Mental health,X29179.Comes through difficult times with little trouble,13995,0.0314742403803766,0.0434200687435227,-0.0536290943569278,0.116577575117681,0.468539184763653
LYZL2,Lysozyme-like protein 2,Mental health,X29180.Tendency to take a long time to get over setbacks,13995,-0.0186173964491582,0.0428648054935971,-0.102632415216609,0.0653976223182922,0.664056788002813
LYZL2,Lysozyme-like protein 2,Mental health,X29181.General happiness,13916,0.0792495816613281,0.044621425388252,-0.00820841209964585,0.166707575422302,0.0757476618018695
LYZL2,Lysozyme-like protein 2,Mental health,X29182.Belief that own life is meaningful,13753,-0.0278642402620262,0.0446440996347665,-0.115366675546169,0.0596381950221161,0.532544954100405
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,9610,-0.066179207971673,0.0516486768417859,-0.167410614581573,0.0350521986382272,0.200107325009819
LYZL2,Lysozyme-like protein 2,Health and medical history,X2946.Father's age,9368,0.00171441803101214,0.00589223021903478,-0.00983435319829603,0.0132631892603203,0.771086451399424
LYZL2,Lysozyme-like protein 2,Health and medical history,X2966.Age high blood pressure diagnosed,10733,-0.00267529583882584,0.00449173422094019,-0.0114790949118686,0.00612850323421693,0.551452234405702
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,41749,0.0136910875353776,0.00191016719669149,0.0099471598298623,0.0174350152408929,7.76537283404232e-13
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,41750,0.0148787630916522,0.00214931937963344,0.0106660971075707,0.0190914290757337,4.49991853674371e-12
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30020.Haemoglobin concentration,41750,0.0103960630241503,0.00230853256860671,0.00587133918968118,0.0149207868586195,6.70807069775884e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30030.Haematocrit percentage,41750,0.0102571072341272,0.00225604053183933,0.00583526779172211,0.0146789466765323,5.46962300045492e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30040.Mean corpuscular volume,41750,-0.00896811618081128,0.00188648353776892,-0.0126656239148384,-0.0052706084467842,2.00214099164409e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,41749,-0.00837096704623358,0.00189382499364936,-0.0120828640337863,-0.00465907005868084,9.88865278676347e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,41749,-0.000765856931630565,0.00185200160756303,-0.00439578008245411,0.00286406621919298,0.67922098357436
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,41750,-0.00301682672770633,0.00184412668529964,-0.00663131503089363,0.000597661575480975,0.101865801565838
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30080.Platelet count,41750,0.0222884749969243,0.00188874926201867,0.0185865264433677,0.0259904235504809,4.35608489960114e-32
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30090.Platelet crit,41750,0.0315048708662725,0.00192884433229413,0.027724335974976,0.035285405757569,8.73813356624443e-60
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,41750,0.00799275325594604,0.00181010038984555,0.00444495649184876,0.0115405500200433,1.00963849966972e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30110.Platelet distribution width,41750,0.00490656524334857,0.00183612409601902,0.00130776201515128,0.00850536847154586,0.00753758811981245
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30120.Lymphocyte count,41686,0.00936174675279587,0.00188124763919457,0.00567450137997451,0.0130489921256172,6.50521875206957e-07
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30130.Monocyte count,41686,0.00523326780118299,0.00190102918595448,0.0015072505967122,0.00895928500565377,0.00591026634709155
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30140.Neutrophill count,41686,0.0122221293337514,0.00189195486637816,0.00851389779565023,0.0159303608718526,1.05817067137709e-10
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30150.Eosinophill count,41686,0.00838311637688588,0.00183656704369418,0.00478344497124528,0.0119827877825265,5.0197646543564e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30160.Basophill count,41686,0.0576494743833044,0.0271161635856757,0.00450179375538002,0.110797155011229,0.0335075538917317
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30170.Nucleated red blood cell count,41686,-0.174526345031441,0.136511988086174,-0.442089841680343,0.093037151617461,0.201091228534544
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30180.Lymphocyte percentage,41687,-0.00228445956084304,0.00185368407645128,-0.00591768035068754,0.00134876122900145,0.217810822130691
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30190.Monocyte percentage,41687,-0.00510389255992541,0.00188032997351892,-0.00878933930802249,-0.00141844581182833,0.00664312695517405
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30200.Neutrophill percentage,41687,0.00319810794870038,0.00183632425104602,-0.000401087583349817,0.00679730348075058,0.0815891171715741
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30210.Eosinophill percentage,41687,0.00397340920827428,0.00181821049548289,0.000409716637127819,0.00753710177942073,0.0288694308030439
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30220.Basophill percentage,41687,0.00258813227224416,0.00181634969153216,-0.00097191312315888,0.00614817766764721,0.154191116031497
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,41686,-0.171787257809587,0.136486483578771,-0.439300765623979,0.095726250004804,0.208167681492502
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30240.Reticulocyte percentage,40987,0.00674143782115802,0.00195323427733118,0.0029130986375889,0.0105697770047271,0.000558200804439142
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30250.Reticulocyte count,40987,0.0095144340470951,0.00199735255800425,0.00559962303340678,0.0134292450607834,1.90892664114375e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30260.Mean reticulocyte volume,40987,-0.00699467740261603,0.00185787898698159,-0.0106361202170999,-0.00335323458813212,0.000166866688747506
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30270.Mean sphered cell volume,40987,-0.00969568521335079,0.00187313178837126,-0.0133670235185585,-0.00602434690814312,2.27530330248776e-07
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30280.Immature reticulocyte fraction,40987,-0.000861941726327552,0.00195232480298362,-0.00468849834017545,0.00296461488752035,0.658856977861061
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,40987,0.00517315748899402,0.00199389645195983,0.00126512044315276,0.00908119453483528,0.00947632912563466
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30300.High light scatter reticulocyte count,40987,0.00733912201914074,0.00202515714387408,0.00336981401714754,0.0113084300211339,0.000290458775147955
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30500.Microalbumin in urine,13590,0.00246515866630852,0.00325184447787298,-0.00390845651032252,0.00883877384293955,0.448416176381491
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,41842,0.000419871909813919,0.00197114712244157,-0.00344357645017155,0.00428332026979939,0.831321047180101
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30520.Potassium in urine,41763,-0.000477553471948221,0.0018380316970179,-0.0040800955981033,0.00312498865420686,0.795005550728828
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30530.Sodium in urine,41743,-0.00294754523035162,0.0019210212229273,-0.00671274682728913,0.000817656366585885,0.124947784096124
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30600.Albumin,37611,0.0104635607329933,0.00198692256003036,0.00656919251533378,0.0143579289506528,1.40030032363022e-07
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30610.Alkaline phosphatase,41030,0.00981482530659608,0.00190461345453479,0.00608178293570788,0.0135478676774843,2.57283930318973e-07
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30620.Alanine aminotransferase,41023,0.00446398147279976,0.00201197899770594,0.000520502637296112,0.0084074603083034,0.0265124705183129
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30630.Apolipoprotein A,37362,-0.00367658198853617,0.00218259070796547,-0.0079544597761485,0.000601295799076159,0.0920927323976089
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30640.Apolipoprotein B,40803,0.0088071915717129,0.00184325273545356,0.00519441621022391,0.0124199669332019,1.77600263544204e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30650.Aspartate aminotransferase,40903,0.00399556826106197,0.00190590845804859,0.000259987683286731,0.0077311488388372,0.0360518391057694
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30660.Direct bilirubin,34788,-0.00622851965397582,0.0020929358292177,-0.0103306738792425,-0.00212636542870913,0.00292261833506811
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30670.Urea,41018,0.00319856044662496,0.00195868819788632,-0.000640468421232233,0.00703758931448216,0.102474245885107
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30680.Calcium,37607,0.0160409622635636,0.00192812879776051,0.012261829819953,0.0198200947071742,9.13164452897015e-17
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30690.Cholesterol,41042,0.00724575246389658,0.00187153583831238,0.00357754222080432,0.0109139627069888,0.000108311065216498
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30700.Creatinine,41028,0.00943175974972906,0.0023027719603828,0.00491832670737877,0.0139451927920794,4.21467181682437e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30710.C-reactive protein,40911,0.00348362841814525,0.00205536737556269,-0.000544891637957613,0.00751214847424812,0.090103274401763
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30720.Cystatin C,41044,0.0109696697861282,0.00218423869068054,0.00668856195239429,0.015250777619862,5.12984693271392e-07
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30730.Gamma glutamyltransferase,41027,0.00478870104883565,0.00205454916863213,0.000761784678316666,0.00881561741935463,0.0197698122112674
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30740.Glucose,37560,0.00217825726332351,0.00198479332934721,-0.00171193766219702,0.00606845218884404,0.272441677291654
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),40867,0.0110285513321479,0.00200139885194313,0.00710580958233937,0.0149512930819565,3.60131891146904e-08
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30760.HDL cholesterol,37581,-0.00944185579101229,0.00227287445061835,-0.0138966897142242,-0.00498702186780033,3.2722364023869e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30770.IGF-1,40828,0.00479701220646615,0.00193236272136549,0.00100958127258979,0.00858444314034251,0.0130518786334018
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30780.LDL direct,40948,0.00733135384352232,0.00184416505698537,0.00371679033183098,0.0109459173552136,7.03719626167723e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30790.Lipoprotein A,32822,0.000113880977747866,0.00206194596549033,-0.00392753311461318,0.00415529507010892,0.955955680273863
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30810.Phosphate,37527,0.00925487515291694,0.00199198665110572,0.00535058131674974,0.0131591689890841,3.39494311476893e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30830.SHBG,37261,-0.0121352390552052,0.00229526112914694,-0.0166339508683332,-0.00763652724207714,1.24980796237503e-07
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30840.Total bilirubin,40879,-0.00439646714758694,0.0019595094825031,-0.00823710573329301,-0.000555828561880876,0.0248598125737447
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30850.Testosterone,37033,0.0075574322532967,0.00320898676793814,0.00126781818813795,0.0138470463184554,0.0185237258424084
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30860.Total protein,37579,0.0145796983263616,0.00196080650978298,0.010736517567187,0.0184228790855363,1.06339643692316e-13
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30870.Triglycerides,41012,0.0239725208152814,0.00199548391461253,0.0200613723426409,0.027883669287922,3.43635451427032e-33
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30880.Urate,40988,0.00706923979096475,0.00232155708483379,0.00251898790469053,0.011619491677239,0.00232795155708957
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30890.Vitamin D,39175,0.00166181262894494,0.00208110709428484,-0.00241715727585334,0.00574078253374321,0.424571685278377
LYZL2,Lysozyme-like protein 2,Physical measures,X3137.Number of measurements made,38999,-0.0142027422610829,0.0310273649805099,-0.0750163776228823,0.0466108931007165,0.647135401382732
LYZL2,Lysozyme-like protein 2,Physical measures,X3143.Ankle spacing width,24266,-0.0147989583237719,0.00330059932419541,-0.0212681329991949,-0.00832978364834889,7.36894706777617e-06
LYZL2,Lysozyme-like protein 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",24265,-0.00324097022908501,0.00253265118880011,-0.00820496655913323,0.00172302610096322,0.200671727743056
LYZL2,Lysozyme-like protein 2,Physical measures,X3146.Speed of sound through heel,24266,-0.000713756847747785,0.00245365306877427,-0.00552291686254535,0.00409540316704978,0.771133664664826
LYZL2,Lysozyme-like protein 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",24266,-0.00168650494226908,0.0024776290173857,-0.00654265781634506,0.0031696479318069,0.496072210497546
LYZL2,Lysozyme-like protein 2,Physical measures,X3148.Heel bone mineral density (BMD),24246,-0.000874210200187396,0.00247930076624088,-0.00573363970201952,0.00398521930164473,0.724388758091578
LYZL2,Lysozyme-like protein 2,Health and medical history,X3526.Mother's age at death,25653,-0.00393658004001743,0.00239844782538582,-0.00863753777777364,0.000764377697738769,0.100746761946494
LYZL2,Lysozyme-like protein 2,Health and medical history,X3581.Age at menopause (last menstrual period),13336,-0.00162373135735186,0.00319138296694789,-0.00787884197256973,0.004631379257866,0.610910574560698
LYZL2,Lysozyme-like protein 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",8469,0.00125335840391628,0.00418762036438823,-0.00695437751028466,0.00946109431811722,0.764717850013529
LYZL2,Lysozyme-like protein 2,Physical measures,X4100.Ankle spacing width (left),14021,-0.000984225360948772,0.00441536093396174,-0.00963833279151378,0.00766988206961623,0.823609287510026
LYZL2,Lysozyme-like protein 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),14019,0.00124940051409208,0.00338425646725693,-0.0053837421617315,0.00788254318991566,0.71199898674987
LYZL2,Lysozyme-like protein 2,Physical measures,X4103.Speed of sound through heel (left),14021,0.00114109562292819,0.00328363271427207,-0.00529482449704506,0.00757701574290144,0.728213332878082
LYZL2,Lysozyme-like protein 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",14021,0.00114082443828521,0.0033146680774771,-0.0053559249935699,0.00763757387014033,0.730720177168363
LYZL2,Lysozyme-like protein 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),14012,0.00111322633320693,0.00331520275901058,-0.00538457107445381,0.00761102374086767,0.737030988853557
LYZL2,Lysozyme-like protein 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",14021,0.00114245690243018,0.00331467345593518,-0.00535430307120277,0.00763921687606312,0.730350279554352
LYZL2,Lysozyme-like protein 2,Physical measures,X4119.Ankle spacing width (right),14007,-0.00146415218938739,0.00436378008035677,-0.0100171611468866,0.00708885676811188,0.737235004625683
LYZL2,Lysozyme-like protein 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),14006,0.00202581981448044,0.00340407578124151,-0.00464616871675292,0.00869780834571381,0.551775587480872
LYZL2,Lysozyme-like protein 2,Physical measures,X4122.Speed of sound through heel (right),14007,0.00333180458424835,0.00328771193478143,-0.00311211080792326,0.00977571997641996,0.310881243459419
LYZL2,Lysozyme-like protein 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",14007,0.00304906406481885,0.00332449281110804,-0.0034669418449529,0.00956506997459061,0.35907898583244
LYZL2,Lysozyme-like protein 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),13996,0.00317846226701154,0.00332661085611094,-0.00334169501096591,0.00969861954498899,0.339358807822348
LYZL2,Lysozyme-like protein 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",14007,0.00304708671957379,0.00332449908961492,-0.00346893149607145,0.00956310493521903,0.359391597783002
LYZL2,Lysozyme-like protein 2,Physical measures,X4194.Pulse rate,14579,-0.0026179145970727,0.00317159863985641,-0.00883424793119126,0.00359841873704586,0.409144260921071
LYZL2,Lysozyme-like protein 2,Physical measures,X4195.Pulse wave reflection index,14579,0.00311083599002898,0.00323074550622302,-0.00322142520216815,0.00944309718222611,0.335621285007709
LYZL2,Lysozyme-like protein 2,Physical measures,X4196.Pulse wave peak to peak time,14570,-0.000750260102990715,0.00321771504281801,-0.00705698158691402,0.00555646138093259,0.815636181300907
LYZL2,Lysozyme-like protein 2,Physical measures,X4198.Position of the pulse wave peak,14579,-0.000478113350308414,0.00324788775157696,-0.00684397334339926,0.00588774664278243,0.882970299333746
LYZL2,Lysozyme-like protein 2,Physical measures,X4199.Position of pulse wave notch,14579,-0.00230851961364496,0.00315013477586519,-0.00848278377434074,0.00386574454705081,0.463672685918126
LYZL2,Lysozyme-like protein 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,14579,-0.00203647399243741,0.00326417059227789,-0.00843424835330207,0.00436130036842725,0.532711489771348
LYZL2,Lysozyme-like protein 2,Physical measures,X4269.Number of triplets attempted (left),14293,-0.209685690228307,0.123699222122078,-0.45213616558758,0.0327647851309661,0.0900734641180658
LYZL2,Lysozyme-like protein 2,Physical measures,X4270.Volume level set by participant (left),14144,-0.0951056262755394,0.0413490024009875,-0.176149670981475,-0.014061581569604,0.0214587232405702
LYZL2,Lysozyme-like protein 2,Physical measures,X4276.Number of triplets attempted (right),14297,-0.155222077713056,0.124091975820808,-0.39844235032184,0.0879981948957276,0.211004924455262
LYZL2,Lysozyme-like protein 2,Physical measures,X4277.Volume level set by participant (right),14139,-0.0666965830892741,0.0409873884282153,-0.147031864408576,0.0136386982300278,0.103707071536117
LYZL2,Lysozyme-like protein 2,Cognitive function,X4288.Time to answer,14604,-0.00096574704499454,0.00370042114448548,-0.00821857248818607,0.00628707839819699,0.794109293624848
LYZL2,Lysozyme-like protein 2,Cognitive function,X4290.Duration screen displayed,14604,-0.00508391357636565,0.00331773915763142,-0.0115866823253232,0.00141885517259193,0.12545955624706
LYZL2,Lysozyme-like protein 2,Physical measures,X46.Hand grip strength (left),42939,-0.00336573662786452,0.00260434337389892,-0.0084702496407064,0.00173877638497736,0.196241130510029
LYZL2,Lysozyme-like protein 2,Physical measures,X47.Hand grip strength (right),42942,-0.00289466583579996,0.00258794075985857,-0.00796702972512276,0.00217769805352284,0.263350843032224
LYZL2,Lysozyme-like protein 2,Physical measures,X48.Waist circumference,43066,0.009961208,0.004019158,0.002083658,0.01783876,0.01319995
LYZL2,Lysozyme-like protein 2,Health and medical history,X4803.Tinnitus,14323,-0.075233475907631,0.0490690552274325,-0.171408824153399,0.0209418723381367,0.12524467908909
LYZL2,Lysozyme-like protein 2,Working and living environment,X4825.Noisy workplace,14523,-0.0339607411615081,0.0560696638952234,-0.143857282396146,0.0759358000731298,0.5447312095926
LYZL2,Lysozyme-like protein 2,Working and living environment,X4836.Loud music exposure frequency,14427,0.0012097189285649,0.069359089227077,-0.134734095956506,0.137153533813636,0.986084731137934
LYZL2,Lysozyme-like protein 2,Physical measures,X49.Hip circumference,43058,-0.0121917699430691,0.00321656730007463,-0.0184962418512153,-0.00588729803492279,0.000150667654285536
LYZL2,Lysozyme-like protein 2,Physical measures,X50.Standing height,43021,-0.0106053813122615,0.00254768294410406,-0.0155988398827054,-0.00561192274181753,3.15041316151357e-05
LYZL2,Lysozyme-like protein 2,Health and medical history,X5057.Number of older siblings,12849,-0.0026446467029217,0.0433473207240446,-0.0876053953220491,0.0823161019162057,0.951351705132519
LYZL2,Lysozyme-like protein 2,Physical measures,X51.Seated height,42834,-0.00394917217088067,0.00237152575418537,-0.00859736264908399,0.000699018307322645,0.0958711375317964
LYZL2,Lysozyme-like protein 2,Eye measures,X5181.Ever had eye surgery,9880,-0.088409913725572,0.105926544796878,-0.296025941527454,0.11920611407631,0.403943930210599
LYZL2,Lysozyme-like protein 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),9856,-0.00172635691203341,0.00379776013033183,-0.0091699667674838,0.00571725294341697,0.6494269247031
LYZL2,Lysozyme-like protein 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),9854,-0.00367002277776345,0.0038357979490756,-0.0111881867579516,0.00384814120242473,0.338700759582912
LYZL2,Lysozyme-like protein 2,Eye measures,X5190.Duration at which refractometer first shown (right),9744,-0.00299216620705505,0.00385588437320438,-0.0105496995785356,0.00456536716442553,0.437767857249308
LYZL2,Lysozyme-like protein 2,Eye measures,X5193.Duration at which refractometer first shown (left),9741,0.000711653408979019,0.00388801335780689,-0.00690885277232249,0.00833215959028053,0.854772174788385
LYZL2,Lysozyme-like protein 2,Eye measures,"X5199.logMAR, initial (right)",9817,0.048384274546918,0.0527012782406573,-0.0549102308047704,0.151678779898606,0.358596742981957
LYZL2,Lysozyme-like protein 2,Eye measures,X5200.Final number of letters displayed (right),9817,0.357031679406262,0.392335540569031,-0.411945980109039,1.12600933892156,0.362836369432991
LYZL2,Lysozyme-like protein 2,Eye measures,"X5201.logMAR, final (right)",9722,-0.000599818875259568,0.00386347685949639,-0.00817223351987249,0.00697259576935336,0.876624583939634
LYZL2,Lysozyme-like protein 2,Eye measures,X5202.Number of rounds to result (right),9817,0.0574237565932896,0.0492628382688952,-0.0391314064137451,0.153978919600324,0.243780031056669
LYZL2,Lysozyme-like protein 2,Eye measures,"X5206.logMAR, initial (left)",9812,-0.0103145708498469,0.0518428511004426,-0.111926559006714,0.0912974173070205,0.842299412452754
LYZL2,Lysozyme-like protein 2,Eye measures,X5207.Final number of letters displayed (left),9812,-0.0139395582662825,0.320010869602871,-0.641160862687909,0.613281746155344,0.965256311591619
LYZL2,Lysozyme-like protein 2,Eye measures,"X5208.logMAR, final (left)",9720,-0.00125012241219634,0.00386589049163714,-0.00882726777580513,0.00632702295141245,0.746420171238874
LYZL2,Lysozyme-like protein 2,Eye measures,X5209.Number of rounds to result (left),9806,0.0249999676412337,0.0495607664053064,-0.0721391345131669,0.122139069795634,0.613970175154567
LYZL2,Lysozyme-like protein 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",9399,0.00565367802885217,0.00385568230046873,-0.00190345928006653,0.0132108153377709,0.142593647928474
LYZL2,Lysozyme-like protein 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",9399,0.0074182834751239,0.00383029777176097,-8.91001575275977e-05,0.0149256671077754,0.0528073488989793
LYZL2,Lysozyme-like protein 2,Eye measures,X5256.Corneal hysteresis (right),9399,0.000618181383854947,0.00388000690755652,-0.00698663215495583,0.00822299492266572,0.87341639915105
LYZL2,Lysozyme-like protein 2,Eye measures,X5257.Corneal resistance factor (right),9399,0.00498589462266081,0.00385060523494614,-0.00256129163783362,0.0125330808831552,0.195409350263918
LYZL2,Lysozyme-like protein 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",9369,0.00773241906575467,0.0038575217345544,0.000171676466028049,0.0152931616654813,0.0450448292385911
LYZL2,Lysozyme-like protein 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",9369,0.00485534290347131,0.00382627908300309,-0.00264416409921475,0.0123548499061574,0.204491768071477
LYZL2,Lysozyme-like protein 2,Eye measures,X5264.Corneal hysteresis (left),9369,-0.0058160745639278,0.00388942038158078,-0.0134393385118261,0.00180718938397054,0.134854855221673
LYZL2,Lysozyme-like protein 2,Eye measures,X5265.Corneal resistance factor (left),9369,-0.00196499337457836,0.0038570975881132,-0.00952490464728024,0.00559491789812352,0.610449760440887
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,9753,0.197529794737164,0.227029708531633,-0.247448433984837,0.642508023459166,0.384288275541459
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",42946,-0.00409579281437596,0.0103123996083303,-0.0243080960467033,0.0161165104179513,0.691242857622296
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",42946,-0.0182879867393412,0.0111502583736747,-0.0401424931517436,0.00356651967306111,0.10098335055705
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",42946,0.00172274210175492,0.0107408327004463,-0.0193292899911198,0.0227747741946296,0.87257315842487
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",42946,-0.00740306350759478,0.00459675425363804,-0.0164127018447253,0.00160657482953578,0.107296534528396
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",42946,0.00684521265599586,0.004231621993428,-0.00144876645112303,0.0151391917631147,0.105748994326493
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",19386,-0.00115678502020391,0.00545634307973312,-0.0118512174564808,0.00953764741607301,0.832103504426812
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",19386,-0.0198419893461968,0.0146850481534013,-0.0486246837268634,0.00894070503446981,0.17665691799663
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",19386,0.00727427101811235,0.0105845482548347,-0.0134714435613636,0.0280199855975883,0.491931033642218
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",19386,0.0131648334354699,0.00646583653825718,0.000491793820485805,0.025837873050454,0.0417578703256513
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,43069,0.00477244915815875,0.0070752819716474,-0.00909510350627015,0.0186400018225877,0.499981705129192
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,43069,-0.00996763226550879,0.0090147388791527,-0.0276365204686481,0.0077012559376305,0.268860863935155
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),43069,0.000645544142861182,0.00699695763013132,-0.0130684928121962,0.0143595810979186,0.926491348740737
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',43069,0.00382818328659563,0.0114203831405542,-0.0185557676688906,0.0262121342420818,0.737471175106699
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),43069,0.0297477482742313,0.0283210302006729,-0.0257614709190875,0.0852569674675501,0.293550881257704
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),43069,0.0207390464112485,0.0194347526635809,-0.01735306880937,0.0588311616318671,0.285927511292897
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,43069,-0.00540507771160215,0.0305273903952137,-0.065238762886221,0.0544286074630167,0.859464718964025
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,42945,0.00263178457369151,0.00588478146818507,-0.00890238710395123,0.0141659562513343,0.654719385641631
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,42945,-0.000972479972950697,0.00999458412554249,-0.020561864859014,0.0186169049131126,0.922488058995818
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,42945,0.00301210481032756,0.00526955741453195,-0.00731622772215505,0.0133404373428102,0.567592671281005
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,42945,0.00547013031647087,0.00876547229814708,-0.0117101953878974,0.0226504560208391,0.532595268222722
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,42945,0.00348914706593676,0.00870278318490837,-0.0135683079764836,0.0205466021083572,0.688478715921322
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,42945,-0.0048624584543581,0.00492326254985765,-0.0145120530520791,0.00478713614336289,0.323329835422278
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,13310,0.00882693541311094,0.0119090682747094,-0.0145148384053194,0.0321687092315413,0.45858863298248
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,13310,0.00182358431188765,0.0102737302184963,-0.0183129269163651,0.0219600955401404,0.859118583286331
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,13310,0.000115911552474215,0.0141004047393322,-0.0275208817366169,0.0277527048415654,0.993441233832695
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,13310,-0.000654179518596743,0.0112274766880755,-0.0226600338272247,0.0213516747900312,0.953537670423185
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,42895,-0.0144276707230096,0.0148461283985524,-0.0435260823841723,0.0146707409381531,0.331148728880642
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,42895,-0.0140606492960645,0.0226097861602842,-0.0583758301702216,0.0302545315780926,0.534021888032835
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,42895,0.00924117630777534,0.0390235456371766,-0.0672449731410909,0.0857273257566416,0.812805116438168
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,42895,0.0372998827667584,0.0375719236178524,-0.0363410875242324,0.110940853057749,0.320832790257021
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,42895,-0.00537587771287788,0.0130378740549323,-0.0309301108605451,0.0201783554347893,0.680101248187554
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,42895,0.0112938884959751,0.0173310165232104,-0.0226749038895173,0.0452626808814674,0.514625578298357
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,42895,-0.00103430155862899,0.00798405509563891,-0.0166830495460812,0.0146144464288233,0.896926319965789
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",13951,-0.00501966871284856,0.0126257480587872,-0.0297661349080714,0.0197267974823743,0.690950343870456
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",13951,-0.0131681201127068,0.0134206519661577,-0.0394725979663759,0.0131363577409624,0.326519370341695
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",13951,-0.033949110744534,0.0184585951008088,-0.0701279571421192,0.00222973565305133,0.0659065349709198
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",13951,0.00862230980519278,0.00648573218924516,-0.00408972528572774,0.0213343448961133,0.18372877689881
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",19496,0.00358324634405361,0.00605415464762309,-0.00828289676528764,0.0154493894533949,0.553947406731451
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",19496,0.00652034760017511,0.00589876225610857,-0.00504122642179769,0.0180819216221479,0.269010542010797
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",19496,0.00121671655666572,0.0054029060154686,-0.00937297923365273,0.0118064123469842,0.821828625502163
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",19497,-0.00349206691971572,0.0127336163185576,-0.0284499549040885,0.0214658210646571,0.783903099055934
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",19497,-0.00322473379812145,0.00762083471458296,-0.0181615698387041,0.0117121022424611,0.672192640199183
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",19497,0.00413211641535475,0.0104042951087254,-0.016260301997747,0.0245245348284565,0.691257614130675
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,42945,-0.00289312938263242,0.0123120420015676,-0.027024731705705,0.0212384729404401,0.814222492764586
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,42945,5.51475542469918e-05,0.00861612544328671,-0.016832458314595,0.0169427534230889,0.99489320046193
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,42945,0.0139260977381535,0.0246836085790914,-0.0344537750768656,0.0623059705531726,0.572631843184732
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,42945,-0.0054014808294895,0.00885828959121657,-0.022763728428274,0.011960766769295,0.542020277290074
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,42945,-0.00387060234131871,0.0100407215543343,-0.023550416587814,0.0158092119051765,0.699875985330657
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),42945,0.0170534954577746,0.0115674287172348,-0.00561866482800561,0.0397256557435548,0.140416653022944
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,42945,0.00160143706586517,0.00383430074021272,-0.00591379238495177,0.0091166665166821,0.676197234766247
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,8381,0.00328379278146193,0.0108461783134601,-0.0179747167129199,0.0245423022758438,0.762080025781181
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,8381,-7.22398687946836e-05,0.0136808257649988,-0.0268866583681923,0.0267421786306029,0.995787017033037
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,8381,-0.00258549453331025,0.00970061552262571,-0.0215987009576566,0.0164277118910361,0.789838461202166
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,8381,0.00961210647906139,0.00868658782845981,-0.00741360566471983,0.0266378186228426,0.268522204498609
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,43133,0.00251071366420826,0.00448308669728538,-0.0062761362624711,0.0112975635908876,0.575454182767811
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,43133,0.00116401741060499,0.0129300769351067,-0.024178933382204,0.026506968203414,0.928268551035105
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,43133,-0.00236367758252524,0.00420013906946448,-0.0105959501586756,0.00586859499362513,0.573600060401638
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,43133,-0.00407774794126976,0.00406628025810978,-0.0120476572471649,0.00389216136462542,0.315953252971218
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,43133,0.00408862049561923,0.00630569572949794,-0.00827054313419672,0.0164477841254352,0.516728965928779
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,43133,-0.00276108676059228,0.0055939085107344,-0.0137251474416317,0.00820297392044715,0.621599609624837
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,43133,0.00174971324990713,0.00436874318129835,-0.00681302338543764,0.0103124498852519,0.688784940291239
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,43133,-0.00115148678075521,0.0127404103363948,-0.026122691040089,0.0238197174785785,0.927985139317223
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,29865,-0.00958490645734442,0.00443637925896695,-0.0182802098049196,-0.00088960310976921,0.0307400129718313
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,29865,0.00427082974131873,0.00463399218459725,-0.00481179494049187,0.0133534544231293,0.356728656151752
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,29865,0.00155851912257121,0.00521544018534125,-0.00866374364069764,0.0117807818858401,0.765073429748426
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,29866,-0.00203391327784931,0.00710606590708568,-0.0159618024557372,0.0118939759000386,0.774709985846976
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,29866,0.00113734731798543,0.00469218155830715,-0.00805932853629659,0.0103340231722674,0.808478090286184
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,42749,0.0035350559779668,0.00451239571273073,-0.00530923961898544,0.012379351574919,0.433390720404843
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,42749,0.00152602316385266,0.00360100454088979,-0.00553194573629133,0.00858399206399664,0.671730533075307
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,42749,-0.00302417760597544,0.00399143381316647,-0.0108473878797817,0.00479903266783084,0.44865454855335
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,42749,0.00833643532406471,0.00725451118371456,-0.00588240659601583,0.0225552772441452,0.250505464377537
LYZL2,Lysozyme-like protein 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),42778,0.00333191579504552,0.00397675850635855,-0.00446253087741724,0.0111263624675083,0.40212123460236
LYZL2,Lysozyme-like protein 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,42778,0.00543011560911986,0.00623397616877354,-0.00678847768167628,0.017648708899916,0.383730808492373
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),42945,0.00299345360488195,0.0039185571191891,-0.00468691834872869,0.0106738255584926,0.44492072083629
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,42945,0.00285279594542405,0.00464491090543269,-0.00625122942922402,0.0119568213200721,0.539101838129698
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,42945,0.000916169684160573,0.00697480141481667,-0.0127544410888801,0.0145867804572012,0.895495707853974
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,42945,-0.00769943540069756,0.00898193735587147,-0.0253040326182056,0.00990516181681051,0.391331845266723
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,42945,0.0153233994501643,0.0096588118310174,-0.00360787173862979,0.0342546706389584,0.112640466835487
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,42945,-0.0110308117231149,0.0115234965594234,-0.0336168649795848,0.0115552415333549,0.33844890017977
LYZL2,Lysozyme-like protein 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",24266,-0.00168700442475608,0.00247763158876217,-0.00654316233872993,0.00316915348921778,0.49594508050832
LYZL2,Lysozyme-like protein 2,Physical activities,X864.Number of days or week walked 10+ minutes,42213,-0.0192733860212626,0.0241816939207442,-0.0666695061059213,0.0281227340633961,0.425441683315239
LYZL2,Lysozyme-like protein 2,Physical activities,X874.Duration of walks,36559,-0.00083702503439947,0.0019248997340154,-0.00460982851306965,0.00293577844427071,0.663680519829271
LYZL2,Lysozyme-like protein 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,40774,-0.0331540519468716,0.0234482095463385,-0.0791125426576951,0.0128044387639518,0.157391034125149
LYZL2,Lysozyme-like protein 2,Physical activities,X894.Duration of moderate activity,31564,0.00527528123997884,0.0285048958438959,-0.0505943146140572,0.0611448770940149,0.853178618593591
LYZL2,Lysozyme-like protein 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,8834,-0.0131059910751354,0.00429436955179494,-0.0215229553966535,-0.00468902675361733,0.00228073472185668
LYZL2,Lysozyme-like protein 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,40726,-0.0385629176880879,0.0242106749288933,-0.0860158405487187,0.00889000517254297,0.111211396098738
LYZL2,Lysozyme-like protein 2,Physical activities,X914.Duration of vigorous activity,22778,-0.00570687997939384,0.0024429388490765,-0.0104950401235838,-0.000918719835203898,0.0194961452267297
